paper
sixteenth
instal
annual
review
research
concern
opiat
system
restrict
paper
publish
concern
behavior
effect
endogen
opiat
peptid
includ
paper
deal
analges
properti
specif
topic
year
includ
stress
toler
depend
eat
drink
gastrointestin
renal
hepat
function
mental
ill
mood
learn
memori
reward
cardiovascular
respons
respir
thermoregul
seizur
neurolog
disord
electricalrel
activ
gener
activ
locomot
develop
immunolog
respons
behavior
almost
year
sinc
discoveri
endogen
opiat
peptid
much
remain
learn
effect
behavior
mechan
involv
action
interest
continu
great
although
term
opioid
longer
use
denot
peptid
opiat
activ
previou
year
much
research
opiat
peptid
concern
abil
modul
behavior
pharmacolog
although
increas
emphasi
physiolog
role
especi
manipul
use
opiat
antagonist
endogen
exogen
becom
obviou
opiat
system
work
isol
instead
highli
interrel
system
includ
neurotransmitt
hormon
function
opiat
system
complex
difficult
discov
paper
review
work
publish
investig
behavior
nonanalges
except
stressinduc
analges
activ
endogen
opiat
system
sixteenth
instal
seri
review
summar
annual
develop
field
still
much
concern
stressinduc
behavior
analgesia
also
chang
activ
selfadministr
opiat
vocal
continu
focu
variabl
affect
opiat
nonopi
natur
stressrel
behavior
well
attempt
specifi
receptor
subtyp
respons
differ
reaction
interest
continu
grow
mechan
function
affect
opiat
toler
depend
special
attempt
link
agent
system
includ
dopamin
serotonin
norepinephrin
nitric
oxid
limit
success
achiev
attempt
use
antagonist
treatment
addict
research
continu
opiat
mediat
feed
attempt
delin
variabl
affect
agonist
stimul
antagonist
inhibit
success
link
opiat
system
eat
disord
still
remain
somewhat
elus
howev
grow
line
evid
indic
opiat
system
might
involv
consumpt
alcohol
although
use
treatment
alcohol
yet
demonstr
role
opiat
system
regul
intak
liquid
gener
less
clear
effect
ethanol
may
reflect
alter
reward
valu
rather
fluid
homeostasi
interest
opiat
modul
gastrointestin
function
decreas
spars
support
previou
find
opiat
inhibit
motil
howev
increas
research
concern
role
opiat
system
renal
function
receptor
specif
variabl
crucial
area
new
gener
abl
drawn
interest
opiat
mediat
mental
ill
continu
recent
trend
declin
although
evid
depress
associ
disturb
hypothalamuspituitaryadren
axi
may
involv
opiat
peptid
symptom
autism
also
seem
modul
area
opiat
mediat
learn
memori
drew
increas
interest
past
year
recent
year
role
opiat
condit
stimuli
classic
condit
especi
condit
place
prefer
receiv
much
attent
abil
act
discrimin
stimuli
oper
task
amnest
properti
agonist
facilit
memori
antagonist
also
studi
mechan
might
involv
opiat
reward
research
regul
cardiovascular
activ
opiat
decreas
request
reprint
address
gayl
olson
olson
olson
somewhat
previou
year
gener
could
drawn
effect
heart
rate
blood
pressur
due
conflict
find
interest
involv
opiat
system
cardiovascular
shock
also
less
previou
year
result
still
confus
attent
opiat
mediat
respir
great
agonist
tend
depress
ventilatori
respons
antagonist
stimul
possibl
relationship
respiratori
disord
endogen
opiat
found
similarli
agonist
produc
hypothermia
case
antagonist
opposit
interact
opiat
system
variabl
receiv
focu
less
interest
opiat
modul
seizur
research
indic
possibl
proconvuls
action
agonist
anticonvuls
effect
k
agonist
although
except
role
opiat
brain
injuri
becam
confus
conflict
result
appear
chang
opiat
system
alzheim
diseas
still
earli
explain
much
relationship
symptom
interest
electricalrel
activ
remain
high
although
overrid
gener
could
drawn
studi
effect
opiat
depend
crucial
area
nervou
system
monitor
mani
effect
also
receptor
specif
wherea
other
seem
modifi
almost
agonist
similarli
although
continu
larg
amount
work
done
opiat
mediat
gener
activ
locomot
definit
conclus
reach
perhap
mani
way
behavior
measur
multipl
variabl
affect
promis
work
possibl
role
opiat
exercis
howev
littl
attent
paid
opiat
modul
sexual
behavior
direct
involv
endogen
opiat
system
develop
prenat
senesc
clear
chang
occur
behavior
receptor
level
although
relationship
two
alway
easili
determin
although
remain
strong
interest
interact
opiat
system
immun
function
littl
abl
determin
conflict
result
occur
nearli
everi
aspect
studi
indic
extrem
complex
relationship
probabl
involv
system
well
much
remain
learn
scant
attent
paid
role
opiat
system
social
behavior
cough
hibern
although
still
continu
studi
final
interest
new
opiat
modul
peptid
long
known
mani
kind
stressor
activ
endogen
opiat
system
thu
produc
opiatemedi
behavior
includ
analgesia
often
opiat
nonopi
natur
stressor
depend
small
differ
ie
intermitt
vs
continu
foot
shock
cold
water
vs
warm
water
swim
well
behavior
measur
ie
analgesia
activ
typic
opiat
natur
determin
abil
antagonist
block
revers
effect
stressor
variabl
contribut
determin
continu
studi
particular
emphasi
interact
opiat
system
physiolog
system
year
one
stressor
receiv
much
attent
foot
shock
one
produc
opiat
nonopi
effect
inescap
intermitt
shock
result
analgesia
revers
naloxon
antagonist
administ
subcutan
sc
intrathec
intraventricularli
icv
suggest
opiat
effect
probabl
spinal
cord
level
naloxon
influenc
morphin
analgesia
somewhat
differ
shockinduc
analgesia
requir
lower
dose
sc
effect
icv
revers
morphin
analgesia
action
probabl
primarili
mediat
receptor
select
receptor
antagonist
naltrindol
effect
analgesia
select
k
antagonist
norbinaltorphimin
either
intraperiton
ip
block
strongli
suggest
spinal
k
receptor
respons
analgesia
prolong
shock
shock
total
min
result
analgesia
mechan
involv
clear
prolong
shock
potenti
morphin
analgesia
indic
desensit
z
receptor
although
glucocorticoid
increas
shock
corticosteroid
inhibitor
caus
otherwis
ineffect
shock
produc
analgesia
indic
mechan
lack
analgesia
corticotropinreleas
hormon
crh
howev
may
interact
opiat
system
shockinduc
analgesia
sinc
antagonist
crh
block
analgesia
intermitt
shock
effect
analgesia
continu
shock
shock
also
affect
behavior
includ
reduct
ot
daili
run
wheel
rat
escap
inescap
shock
find
opposit
shockinduc
analgesia
occur
inescap
shock
perhap
daili
run
part
fear
respons
analgesia
regardless
naltrexon
alter
suppress
run
shock
indic
probabl
opiat
effect
anoth
respons
shock
increas
selfadministr
opiat
rat
lever
press
access
fentanyl
solut
sped
shock
water
quinin
similar
tast
fentanyl
substitut
agonist
extinct
occur
indic
opiat
action
involv
chang
stressreleas
endogen
opiat
potenti
exogen
one
repeat
daili
shock
produc
increas
rate
ot
biosynthesi
proopiomelanocortin
pomc
pomc
mrna
rate
convers
pomc
end
product
shift
ratio
decreas
proport
endorphin
releas
anterior
pituitari
suggest
peptiderg
endocrin
cell
may
deliv
somewhat
differ
messag
target
depend
upon
regulatori
adapt
need
occur
repeat
demand
intermitt
chronic
shock
increas
concentr
immunoreact
splenocyt
lymph
node
cell
peripher
blood
mononuclear
cell
rise
block
crh
antagonist
suggest
interact
opiat
peptid
crh
mediat
effect
stress
immun
system
infus
icv
inhibit
releas
ofcortisol
plasma
shock
sheep
increas
nonstress
one
furthermor
induc
releas
prolactin
stress
anim
antiserum
stress
increas
cortisol
aggrav
stress
symptom
indic
role
endogen
opiat
mediat
stress
foot
shock
forc
swim
shown
induc
opiat
nonopi
analgesia
coldwat
swim
swim
water
intermedi
warm
temperatur
produc
analgesia
varieti
condit
although
continu
coldwat
swim
ccw
typic
produc
nonopi
analgesia
activ
opiat
system
pretreat
either
morphin
naltrexon
alter
analgesia
demonstr
interact
opiat
nonopi
system
nocicept
similarli
although
coldwat
swim
durat
result
analgesia
mice
shift
doserespons
curv
morphin
analgesia
left
thu
support
lack
independ
two
kind
analgesia
intermitt
coldwat
swim
icw
usual
produc
opiatemedi
analgesia
confirm
find
pretreat
naltrexon
reduc
analgesia
chronic
present
ccwss
icw
develop
toler
toler
provid
addit
evid
interact
opiat
nonopi
analgesia
mechan
analgesia
swim
water
nonopi
water
least
partial
opiat
temperatur
water
critic
underli
mechan
short
swim
result
nonopi
analgesia
longer
one
produc
opiat
antinocicept
demonstr
length
swim
anoth
crucial
variabl
attempt
determin
receptor
subtyp
modul
cw
analgesia
specif
antagonist
coadminist
morphin
cw
antagonist
ici
antagonist
effect
morphin
analgesia
inhibit
leftward
shift
morphin
doserespons
curv
swim
antagonist
leu
enkephalin
effect
either
measur
suggest
involv
receptor
swim
analgesia
u
inhibit
morphin
analgesia
swim
affect
receptor
probabl
involv
swim
analgesia
neither
leunor
metenkephalin
alter
morphin
analgesia
antibodi
metenkephalin
effect
swim
analgesia
antibodi
leuenkephalin
inhibit
find
indic
receptor
may
modul
primari
action
mediat
receptor
rat
howev
repeat
cwss
day
produc
analgesia
increas
naltrexon
reduc
morphin
differ
possibl
due
speci
differ
repeat
measur
result
collater
inhibit
action
sex
differ
found
abil
naloxon
revers
analgesia
water
swim
although
naloxon
revers
male
affect
antagonist
femal
whether
intact
gonadectom
addit
estrogen
alter
find
mechan
respons
sex
differ
clear
highlight
need
consid
gender
factor
research
clinic
practic
regard
pain
similarli
breed
male
experienc
greater
swim
analgesia
breed
femal
sex
differ
nonbreed
mice
reproduct
statu
must
also
taken
account
genet
factor
also
import
strain
mice
select
bred
high
swim
analgesia
low
swim
analgesia
also
interact
opiat
system
thyrotropinreleas
hormon
trh
ccw
analgesia
inject
trh
posterior
periaqueduct
gray
facilit
analgesia
anterior
area
reduc
age
critic
variabl
although
seemingli
conflict
studi
may
incompat
first
appear
one
studi
report
swim
stress
analgesia
warm
water
absent
day
rat
time
occur
low
level
naloxon
revers
adult
profil
fulli
develop
day
anoth
report
found
wean
statu
affect
swim
analgesia
naloxon
partial
revers
analgesia
rat
whether
wean
naltrindol
revers
wean
anim
day
naltrindol
block
analgesia
complet
lead
conclus
transit
u
receptor
control
respons
affect
wean
appar
contradictori
find
swim
analgesia
preweanl
rat
weak
naloxon
revers
show
normal
adult
naloxonerevers
level
wean
rat
reconcil
studi
former
use
higher
dose
naloxon
would
make
like
would
antagon
opiat
effect
use
differ
measur
analgesia
use
tail
water
immers
test
essenti
spinal
reflex
conflict
studi
use
tail
electr
stimul
test
measur
vocal
afterdischarg
threshold
tail
withdraw
vocal
addit
assess
emot
affect
reaction
pain
thu
may
differenti
nocicept
respons
differ
level
neural
integr
anoth
chang
occur
result
swim
stress
well
stress
associ
handl
constant
sound
novel
environ
stimul
releas
ofcorticosteron
increas
attenu
administr
ainterferon
suggest
possibl
mechan
effect
stress
physic
health
action
ainterferon
block
naloxon
mainli
u
antagonist
naloxonazin
antagonist
naltrindol
antagonist
norbinaltorphimin
k
antagonist
indic
interact
immun
opiat
system
respons
stress
differ
line
support
idea
endogen
opiat
system
play
role
swim
stress
came
find
swim
immunoreact
singl
acut
swim
chronic
swim
rais
plasma
although
increas
acut
swim
block
apomorphin
produc
chronic
swim
question
role
dopamin
respons
furthermor
dopamin
antagonist
haloperidol
present
chronic
swim
increas
pomc
mrna
support
nondopaminerg
aspect
reaction
chronic
icwss
rais
endorphin
plasma
anterior
pituitari
day
time
decreas
pituitari
concentr
perhap
habitu
toler
similarli
increas
neurointermedi
pituitari
endorphin
respons
combin
icwss
ether
disappear
day
exposur
administr
acetylcarnitin
neurotrop
drug
act
cholinerg
serotonerg
gabaerg
pathway
block
effect
swim
indic
complex
interact
evid
idea
come
report
rat
subject
swim
corticosteron
exhibit
transitori
increas
swim
salin
sustain
rise
peptid
appear
littl
doubt
stress
produc
dysfunct
hypothalamopituitaryadren
hpa
axi
restraint
anoth
frequent
use
stressor
studi
opiat
effect
potenti
morphin
analgesia
naltrexon
block
action
morphin
indic
opiat
natur
chronic
naloxon
howev
appear
produc
upregul
opiat
receptor
antagonist
potenti
morphin
analgesia
given
restraint
result
even
greater
potenti
either
alon
upregul
transitori
day
remov
naloxon
longer
potenti
morphin
analgesia
restraint
also
induc
biphas
reaction
heart
rate
transitori
increas
follow
reduct
addit
stress
noxiou
tail
clip
potenti
effect
nonopi
naloxon
alter
revers
olson
olson
kastin
true
bodi
temperatur
restraint
produc
hypothermia
accentu
naloxon
unaffect
tail
clip
naloxon
block
effect
restraint
doubt
respons
mediat
opiat
receptor
immobil
stress
day
period
opiat
selfadministr
increas
amount
drug
selfadminist
harsh
subsequ
naloxoneprecipit
withdraw
suggest
stress
help
develop
toler
opiat
find
exposur
restraint
selfadministr
procedur
affect
either
measur
indic
probabl
learn
associ
stress
drug
avail
mediat
toler
support
idea
least
effect
restraint
stress
opiat
modul
come
report
immobil
result
decreas
endorphinlik
immunoreact
periaqueduct
gray
pituitari
day
later
suggest
central
opiat
effect
restraint
pregnant
rat
day
earli
gestat
rais
concentr
hypothalamu
offspr
test
postnat
day
longer
restraint
day
effect
indic
stress
embryon
period
affect
develop
endogen
opiat
system
amount
chang
depend
length
exposur
stress
restraint
young
pig
increas
plasma
adrenocorticotrop
hormon
acth
cortisol
prolactin
growth
hormon
initi
naloxon
potenti
growth
hormon
chronic
exposur
immobil
short
period
day
naloxon
inhibit
product
growth
hormon
indic
interact
role
endogen
opiat
system
pituitaryadrenocort
respons
endogen
opiat
system
may
involv
stress
associ
fight
defens
although
defeat
typic
shown
produc
nonopi
analgesia
rat
expos
defeat
repeatedli
exhibit
analgesia
enhanc
naltrexon
attenu
morphin
analgesia
indic
possibl
interact
opiat
nonopi
mechan
analgesia
effect
avers
encount
long
last
week
brief
exposur
attack
rat
still
reduc
sensit
morphin
analgesia
brief
exposur
meadow
vole
microthu
pennsylvanicu
natur
predat
garter
snake
produc
nonopi
analgesia
inhibit
serotonin
agonist
longer
exposur
result
naloxonerevers
analgesia
analgesia
decreas
age
threat
present
snake
decreas
rat
place
cage
anoth
resid
readili
emit
ultrason
vocal
indic
stress
suppress
morphin
naltrexon
revers
action
morphin
affect
respons
appear
opiat
mediat
even
threat
encount
suffici
produc
vocal
suggest
emot
factor
well
physic
one
involv
respons
similarli
threat
captur
cynomolgu
monkey
macacafasciculari
produc
reaction
increas
heart
rate
chang
occur
monkey
pretreat
naloxon
assum
respons
opiat
mediat
concentr
immunoreact
increas
support
idea
peptid
might
involv
respons
test
nonaggress
partner
neutral
cage
morphinetoler
rat
given
naloxon
precipit
withdraw
demonstr
confront
defens
respons
like
backward
movement
upright
postur
naloxon
methylbromid
given
directli
periaqueduct
gray
produc
respons
addit
ultrason
vocal
find
suggest
involv
endogen
opiat
system
specif
defens
strategi
involv
periaqueduct
gray
rat
kind
social
behavior
creat
opiatemedi
stress
behavior
lack
social
behavior
also
isol
rat
pup
induc
ultrason
vocal
attenu
morphin
glyol
enkephalin
damgo
enkephalin
dpdpe
induc
analgesia
hypertens
occur
rat
pup
subject
isol
probabl
mediat
endogen
opiat
system
chronic
treatment
morphin
inhibit
withdraw
morphin
result
return
high
arteri
pressur
even
undisturb
home
cage
presenc
litterm
situat
rare
produc
ultrason
vocal
inject
lpyrrolidinyl
cyclohexyl
benzeneacetamid
highli
select
k
agonist
elicit
ultrason
vocal
sign
stress
naltrexon
effect
howev
call
question
role
endogen
opiat
system
reaction
handl
earli
life
appear
stress
rat
test
sever
week
handl
analgesia
rel
nonhandl
control
test
second
time
sever
week
first
test
differ
attenu
respons
analgesia
handl
rat
might
indic
earli
handl
stress
produc
upregul
opiat
system
remain
function
although
weaken
consider
time
sex
differ
suscept
stressor
male
unaffect
neonat
handl
alon
femal
analges
opiat
natur
analgesia
indic
potenti
morphin
case
combin
prenat
stress
howev
handl
produc
hyperalgesia
sex
suggest
may
offset
effect
prenat
stress
novelti
stressor
result
opiatemedi
analgesia
naloxon
attenu
pretreat
c
rnoradrenerg
receptor
antagonist
prazosin
nonselect
c
antagonist
phentolamin
effect
action
naloxon
yohimbin
antagonist
potenti
clonidin
agonist
revers
action
yohimbin
indic
respons
involv
receptor
noveltyinduc
analgesia
affect
toler
morphin
analgesia
suggest
nonopi
effect
chronic
naloxon
produc
analgesia
attenu
habitu
noveltyinduc
hypoalgesia
might
opiat
effect
involv
habitu
modifi
nonopi
antinocicept
effect
anoth
stressor
seem
opiat
substrat
interact
system
restrict
food
prolong
morphineinduc
locomot
intact
adrenalectom
rat
endogen
corticosteron
necessari
respons
replac
exogen
hormon
ineffect
indic
secret
hormon
one
mechan
stressor
work
chicken
food
restrict
increas
concentr
dynorphin
brain
normal
endorphinor
leuenkephalinlik
immunoreact
brain
possibl
indic
role
k
receptor
respons
exposur
extrem
temperatur
also
use
stress
stimulu
although
confin
cold
room
littl
cloth
short
time
min
affect
plasma
men
submers
cold
cool
water
longer
period
min
produc
increas
peptid
relationship
rise
time
immers
variabl
difficult
interpret
find
perhap
immers
temperatur
stress
cold
pressor
test
caus
releas
epinephrin
norepinephrin
block
highli
select
agonist
deltorphin
suggest
opiat
receptor
mediat
effect
number
stressor
shown
elicit
opiat
system
respons
administr
ether
increas
pituitari
immunoreact
chronic
seizur
stimul
biosynthesi
pomc
pomc
mrna
pituitari
inject
hyperton
salin
rais
proenkephalin
mrna
paraventricular
nucleu
rat
chronic
exposur
weak
magnet
field
naloxon
produc
hypoalgesia
snail
cepaea
nernorali
consist
either
facilit
avers
condit
andor
antagon
excitatori
hyperalges
effect
low
amount
endogen
opiat
human
stress
difficult
task
perceiv
failur
increas
rather
decreas
report
pain
cold
although
clear
whether
effect
due
chang
report
sensit
avers
stimuli
involv
endogen
opiat
system
also
delin
sinc
discoveri
endogen
opiat
peptid
interest
relat
opiat
toler
depend
extrem
high
perhap
behavior
associ
opiat
research
investig
mechan
variabl
affect
becom
clear
much
receptor
specif
toler
depend
although
crosstoler
also
exist
particular
interest
focus
withdraw
opiat
increasingli
recogn
complex
area
found
past
year
chronic
treatment
exogen
opiat
agonist
antagonist
alter
endogen
opiat
system
concentr
peptid
present
brain
receptor
activ
find
conting
upon
specif
peptid
measur
area
assess
toler
morphin
increas
immunoreact
thorac
cervic
region
spinal
cord
medulla
indic
dissoci
regul
peptid
spinal
cord
part
central
nervou
system
cn
spinal
cord
chronic
morphin
produc
increas
bind
site
agonist
deltorphini
ligand
receptor
may
special
relev
regard
develop
toler
spinal
cord
although
chronic
morphin
produc
chang
dynorphin
immunoreact
brain
remov
morphin
rat
reduc
dynorphin
nucleu
accumben
suggest
possibl
suppress
role
dynorphinerg
neuron
limbic
system
depend
although
natur
unclear
dynorphin
increas
hypothalamu
hippocampu
ponsmedulla
depend
abstin
produc
increas
dynorphin
midbrain
concentr
peptid
also
increas
heart
toler
abstin
anim
withdraw
result
chang
dynorphin
bodi
tissu
find
differ
found
morphin
depend
suggest
chronic
stimul
u
receptor
produc
differ
effect
k
receptor
nevertheless
toler
increas
u
bind
brain
decreas
spinal
cord
suggest
chronic
stimul
r
agonist
alter
receptor
interact
among
receptor
subtyp
appar
although
probabl
limit
seen
discuss
crosstoler
support
role
receptor
depend
came
find
butorphanol
shown
act
u
k
receptor
decreas
densiti
affin
receptor
brain
seem
though
chang
opiat
bind
concentr
repeat
administr
opiat
agonist
correl
potenc
given
opiat
produc
acut
effect
comparison
across
peptid
difficult
make
chronic
administr
ofopi
antagonist
also
alter
endogen
opiat
system
chronic
naltrexon
increas
bind
damgo
brain
spinal
cord
support
idea
upregul
u
receptor
occur
situat
similarli
continu
infus
naloxon
increas
number
ofu
bind
site
spinal
cord
measur
dala
deltorphin
respect
howev
chronic
naloxon
affect
concentr
spinal
cord
medulla
suggest
action
receptor
specif
chronic
norbinaltorphimin
block
chang
receptor
bind
occur
chronic
butorphin
thought
mediat
k
receptor
support
notion
receptor
specif
demonstr
mani
time
chronic
administr
morphin
produc
behavior
toler
wide
varieti
measur
analgesia
common
agonist
also
shown
produc
toler
depend
given
repeatedli
continu
includ
damgo
agonist
trimu
enkephalin
analogu
nme
giy
tap
butorphanol
bremazocin
tap
produc
analgesia
damgo
morphin
develop
less
depend
suggest
tap
might
clinic
signific
first
demonstr
toler
nonmammalian
vertebr
speci
toler
chronic
morphin
exhibit
northern
grass
frog
rana
pipien
day
previous
shown
invertebr
howev
gener
tend
crosstoler
among
agonist
receptor
subtyp
littl
among
agonist
affin
differ
subtyp
except
rule
note
like
result
techniqu
use
measur
toler
perhap
speci
mice
tend
show
crosstoler
rat
crosstoler
found
ligand
morphin
damgo
k
agonist
bremazocin
suggest
might
affin
differ
subtyp
k
receptor
despit
report
crosstoler
morphin
delta
agonist
tyrdser
otbu
glypheleuthr
dstbulet
measur
amount
chang
respons
ot
neuron
spinal
cord
rat
acut
challeng
crosstoler
morphin
ligand
dpdpe
measur
attenu
analgesia
morphinedepend
mice
morphin
crosstoler
test
howev
also
conflict
report
crosstoler
morphin
u
none
found
measur
chang
electr
discharg
activ
oxytocinsecret
neuron
rat
supraopt
nucleu
crosstoler
report
measur
analgesia
mice
crosstoler
develop
morphin
serotonin
analgesia
produc
serotonin
attenu
mice
implant
morphin
pellet
similarli
crosstoler
morphin
agonist
dexmedetomidim
although
agonist
dstbulet
crosstoler
measur
either
behavior
analgesia
electrophysiolog
respons
characterist
neuron
spinal
cord
thu
research
crosstoler
kind
studi
demonstr
interact
opiat
system
system
role
serotonin
opiatemedi
behavior
also
demonstr
find
agent
increas
serotonerg
neurotransmiss
also
attenu
hyperact
locu
coeruleu
neuron
induc
withdraw
morphin
perhap
due
decreas
augment
excitatori
amino
acid
input
neuron
agent
calcium
channel
agonist
bay
k
antagonist
nimodipin
diltiazem
reduc
symptom
naloxoneprecipit
withdraw
morphin
affect
metabol
serotonin
withdraw
symptom
least
independ
serotonin
thu
role
serotonin
withdraw
confus
interact
dopamin
opiat
system
also
receiv
attent
chronic
morphin
increas
dopamin
concentr
nucleu
accumben
medulla
depend
rat
acut
morphin
produc
greater
increas
dopamin
nucleu
accumben
decreas
hypothalamu
dopamin
deplet
amethylptyrosin
retard
striatum
rest
forebrain
midbrain
mice
remov
repeat
morphin
treatment
support
role
dopamin
opiat
depend
withdraw
also
caus
decreas
electr
evok
dopamin
striatum
chang
long
last
indic
may
play
part
mainten
depend
appear
receptor
import
depend
nonselect
dopamin
agonist
apomorphin
select
agonist
propylnorapomorphin
reduc
withdraw
sign
agonist
produc
effect
withdraw
dj
receptorstimul
releas
camp
striatal
slice
enhanc
rat
treat
chronic
morphin
reduc
chronic
naltrexon
di
receptor
might
indirect
effect
morphin
depend
chronic
supersensit
receptor
morphin
might
role
k
receptor
depend
system
seem
play
role
opiat
toler
withdraw
acut
damgo
chronic
morphin
releas
norepinephrin
cortic
slice
although
addit
effect
combin
acut
morphin
produc
deplet
norepinephrin
hypothalamu
forebrain
striatum
midbrain
effect
develop
toler
chronic
administr
furthermor
toler
morphin
withdraw
produc
chang
system
especi
pyramid
neuron
addit
symptom
naloxoneprecipit
withdraw
morphinedepend
mice
attenu
administr
antagonist
propranolol
atenolol
suggest
might
effect
treatment
opiat
addict
clearli
therefor
interact
adrenerg
opiat
system
excitatori
amino
acid
nmethyldaspart
nmda
may
involv
opiat
depend
antagonist
block
develop
toler
morphin
toler
also
attenu
anoth
nmda
antagonist
ly
withdraw
symptom
precipit
naloxon
morphinedepend
rat
inhibit
suggest
effect
withdraw
direct
block
develop
rather
express
depend
nmda
antagonist
reduc
distress
vocal
social
play
young
rat
clear
whether
inhibit
toler
artifact
behavior
effect
real
blockad
effect
morphin
pretreat
inhibit
develop
toler
chronic
also
limit
interact
receptor
similarli
nitric
oxid
seem
play
role
develop
toler
inhibitor
nmonomethyllarginin
analogu
attenu
effect
chronic
opiat
agonist
inhibitor
nitric
oxid
synthas
reduc
toler
damgo
challeng
morphinetoler
rat
loss
analgesia
hypothermia
mice
inhibitor
also
reduc
withdraw
symptom
weight
loss
wetdog
shake
jump
suggest
nitric
oxid
might
play
role
hyperact
respons
withdraw
nitric
oxid
thu
may
involv
toler
u
k
agonist
benzodiazepin
receptor
also
import
respons
chronic
opiat
stimul
chronic
morphin
increas
benzodiazepin
bind
brain
furthermor
benzodiazepin
agonist
midazolam
diazepam
partial
block
develop
toler
depend
continu
morphin
infus
attenu
naloxoneprecipit
withdraw
morphinedepend
rat
effect
may
mediat
chang
concentr
metenkephalin
brain
spinal
cord
morphin
reduc
diazepam
inhibit
reduct
muscarin
receptor
likewis
influenc
morphin
depend
two
muscarin
antagonist
pirenzepin
methiodid
attenu
withdraw
symptom
perhap
inhibit
spinal
supraspin
cholinerg
neuron
toler
morphin
reduc
spontan
electr
activ
oxytocinsecret
neuron
supraopt
nucleu
therebi
reduc
plasma
oxytocin
chronic
increas
thatz
k
receptor
seem
involv
seem
therefor
larg
number
physiolog
agent
contribut
opiat
toler
depend
acut
morphin
increas
plasma
corticosteron
chronic
morphin
elimin
respons
due
toler
corticosteron
may
play
role
opiat
depend
rise
steroid
howev
also
symptom
withdraw
hormon
may
indirectli
involv
mechan
stress
opiat
toler
depend
could
due
function
decoupl
opiat
receptor
gprotein
subsequ
decreas
endogen
opiat
peptid
nmda
receptor
could
mediat
respons
increas
intracellular
calcium
sign
naloxoneprecipit
withdraw
morphinedepend
rat
attenu
pertussi
toxin
suggest
gprotein
sensit
toxin
may
play
role
depend
question
involv
gprotein
howev
came
find
concentr
chang
chronic
morphin
rat
although
strain
differ
spraguedawley
rat
exhibit
alter
depend
area
brain
specif
gprotein
measur
activ
locu
coeruleu
influenc
chronic
opiat
stimul
morphin
increas
campdepend
protein
kinas
adenyl
cyclas
adenyl
cyclas
mrna
transcript
area
morphin
also
reduc
catechol
oxid
current
ca
oc
locu
coeruleu
naloxoneprecipit
withdraw
increas
ca
oc
signal
respons
attenu
excitatori
amino
acid
antagonist
suggest
mediat
part
excitatori
amino
acid
pathway
hyperact
locu
coeruleu
due
naloxoneprecipit
withdraw
also
reduc
administr
agent
increas
serotonerg
neurotransmiss
perhap
decreas
augment
excitatori
amino
acid
input
locu
coeruleu
lesion
locu
coeruleu
attenu
symptom
withdraw
support
idea
addit
releas
glutam
area
withdraw
perhap
contribut
activ
locu
coeruleu
neuron
prolong
opiat
treatment
includ
ethylketocyclazocin
dynorphin
dadl
enkephalin
increas
concentr
synapsin
immunoreact
spinal
cord
cultur
suggest
synapsin
could
contribut
develop
toler
autonom
area
rat
brain
exhibit
increas
loslik
immunoreact
withdraw
rat
especi
medullari
nuclei
paraventricular
nucleu
amygdala
autonom
area
activ
withdraw
may
contribut
autonom
symptom
area
includ
hypothalamu
striatum
cerebellum
also
show
dramat
chang
cfo
mrna
withdraw
fosb
junb
mrna
littl
chang
indic
alter
gene
express
withdraw
repeat
administr
morphin
increas
cck
immunoreact
cck
mrna
hypothalamu
brain
stem
spinal
cord
chronic
morphin
stimul
stimul
endogen
cck
biosynthesi
indic
interact
neither
chronic
morphin
naloxoneprecipit
withdraw
howev
produc
chang
express
mrna
encod
galatin
neuropeptid
crh
somatostatin
may
play
role
opiat
depend
least
area
brain
studi
learn
demonstr
influenc
toler
depend
state
becom
link
event
occur
establish
classic
condit
involv
environ
condit
stimulu
effect
drug
uncondit
stimulu
environ
come
elicit
drug
effect
morphinedepend
rat
given
naloxon
presenc
distinct
tone
smell
later
test
stimuli
lever
press
suppress
rel
undergon
withdraw
pair
stimuli
behavior
disrupt
absenc
receptor
occup
statedepend
behavior
involv
opiat
withdraw
also
demonstr
rat
given
morphin
put
box
previous
pair
shock
subject
naloxoneprecipit
withdraw
group
demonstr
withdraw
symptom
receiv
morphin
naloxon
box
associ
shock
indic
learn
contextu
fear
exacerb
acut
withdraw
toler
divid
two
class
disposit
nonassoci
condit
associ
differenti
test
analgesia
place
previous
associ
associ
morphin
disposit
toler
found
sc
administr
form
exhibit
iv
administr
explan
result
howev
given
interestingli
report
experi
pain
antagon
develop
morphin
depend
toler
morphin
administ
daili
develop
day
anim
test
daili
analgesia
test
day
analgesia
still
remain
similarli
rat
given
morphin
daili
half
test
analgesia
wherea
half
given
naloxoneprecipit
withdraw
symptom
much
greater
anim
test
pain
day
consist
clinic
studi
show
patient
take
morphin
pain
develop
much
depend
need
increas
pain
medic
cancer
patient
due
progress
diseas
produc
pain
rather
toler
morphin
demand
increas
dose
diseas
stabl
remiss
frequent
test
depend
opiat
appear
withdraw
symptom
either
remov
agonist
administr
opiat
antagonist
latter
method
typic
use
surprisingli
howev
withdraw
sign
differ
two
techniqu
common
symptom
found
teeth
chatter
wetdog
shake
diarrhea
jump
ptosi
weight
loss
chang
activ
level
rear
tremor
yawn
ejacul
chang
temperatur
saliv
mouth
respons
urin
defec
sign
note
also
includ
chang
activ
groom
writh
gasp
eye
twitch
piloerect
chang
heart
rate
blood
pressur
social
behavior
defens
respons
presenc
rat
chang
oper
behavior
escap
disrupt
respond
reward
increas
selfadministr
heroin
increas
icss
threshold
chang
hormon
neurotransmitt
increas
plasma
corticosteron
increas
releas
norepinephrin
acetylcholin
dopamin
appear
differ
mechan
morphinedepend
mice
naloxoneprecipit
withdraw
sign
jump
diarrhea
differenti
reactiv
two
depend
rout
administr
thu
indic
differenti
import
spinal
supraspin
site
respons
age
anoth
factor
influenc
appear
withdraw
symptom
weekold
rat
head
movement
roll
stretch
walk
wall
climb
decreas
time
spent
litterm
one
common
respons
withdraw
adult
rat
induct
withdraw
conting
agonist
use
develop
depend
antagonist
use
precipit
withdraw
morphinedepend
anim
naltrexon
produc
withdraw
suppress
naloxoneprecipit
withdraw
symptom
support
role
receptor
morphin
depend
administr
methylnaloxonium
locu
coeruleu
morphinedepend
rat
induc
behavior
characterist
withdraw
indic
structur
might
primari
site
withdraw
howev
naloxon
given
icv
precipit
withdraw
depend
mice
although
sc
inject
produc
suggest
may
methodolog
confound
effect
studi
use
icv
naloxon
produc
withdraw
rout
effect
produc
rapid
withdraw
measur
jump
morphinedepend
rat
endogen
antiopi
protect
enzym
inhibitor
bestatin
precipit
withdraw
fmrfamid
two
conform
constrain
peptidomimet
dansylprogli
argph
amid
analogu
mammalian
form
neuropeptid
ff
neuropeptid
ff
howev
alter
develop
toler
chronic
morphin
despit
fact
act
like
antiopi
test
naltriben
antagonist
analogu
naltrindol
produc
withdraw
morphinedepend
mice
chronic
pretreat
morphin
slow
develop
depend
measur
sever
naloxoneprecipit
withdraw
chronic
naltriben
rather
implant
morphin
pellet
effect
antagonist
effect
morphinena
anim
indic
role
receptor
depend
morphin
rat
made
depend
butorphanol
k
antagonist
norbinaltorphimin
antagonist
naltrindol
u
antagonist
naloxon
precipit
withdraw
antagonist
pretreat
concurr
treatment
butorphanol
naltrindol
norbinaltorphimin
markedli
block
sign
naloxoneprecipit
withdraw
suggest
either
antagonist
greatli
attenu
develop
toler
studi
togeth
indic
butorphanol
depend
involv
three
main
receptor
subtyp
even
absenc
crosstoler
one
opiat
agonist
affect
withdraw
symptom
differ
anoth
agonist
dynorphin
nonopi
dynorphin
analogu
destyrt
dynorphin
block
toler
withdraw
anim
chronic
morphin
dynorphin
b
cneoendorphin
effect
although
alon
alter
morphin
withdraw
pretreat
norbinaltorphimin
inhibit
withdraw
symptom
naloxon
potenti
hyperact
withdraw
guinea
pig
ileum
norbinaltorphimin
produc
withdraw
contract
k
receptor
develop
acut
depend
nonmorphinelik
cn
morphinelik
enter
nervou
system
morphin
toler
affect
analgesia
produc
agonist
bubu
tyrdser
otbutyl
glypheleuthr
otbutyl
select
antagonist
naltrindol
block
demonstr
receptor
specif
chronic
stimul
opiat
receptor
also
produc
effect
typic
use
measur
toler
depend
chronic
morphin
slightli
increas
threshold
intracrani
selfstimul
icss
naloxoneprecipitar
withdraw
greatli
increas
thu
reduc
pleasur
rat
receiv
naloxoneprecipit
withdraw
morphinedepend
rat
suppress
respond
food
inhibit
condit
suppress
establish
pair
novel
stimulu
inject
naloxon
thu
indic
disrupt
oper
behavior
due
withdraw
isol
guinea
pig
ileum
depend
measur
magnitud
withdraw
develop
littl
min
indic
prolong
exposur
necessari
chronic
opiat
agonist
produc
toler
depend
chronic
antagonist
produc
effect
implant
naltrexon
pellet
rat
increas
bind
site
affin
chronic
naltrexon
produc
upregul
u
receptor
continu
infus
naloxon
increas
bind
site
deltorphini
spinal
cord
indic
u
receptor
underw
upregul
chronic
antagonist
two
day
treatment
naloxon
day
increas
benzodiazepin
receptor
bind
cortex
appear
interact
gabaerg
opiat
system
earli
stage
depend
chronic
blockad
u
receptor
naloxon
produc
supersensit
u
agonist
respons
morphin
attenu
continu
infus
naloxon
behavior
daili
inject
naloxon
produc
hypoalgesia
deer
mice
anim
also
test
pain
daili
indic
involv
avers
condit
effect
cours
much
interest
applic
find
clinic
treatment
addict
limit
success
achiev
although
hope
remain
breakthrough
occur
buprenorphin
compar
methadon
use
mainten
opiat
depend
buprenorphin
reduc
illicit
opiat
use
effect
methadon
retent
rate
less
methadon
withdraw
symptom
associ
greater
methadon
unlik
becom
drug
treatment
similarli
naltrexon
fell
short
expect
abus
potenti
patient
abus
left
program
three
four
commit
suicid
new
drug
levomethadyl
acet
laam
longer
last
methadon
advantag
need
taken
everi
day
risk
accident
overdos
slow
onset
action
unclear
use
treatment
addict
maintain
methadon
stay
treatment
program
better
vehicl
larg
dose
reduc
rate
illicit
opiat
use
continu
use
treatment
still
recommend
find
report
suggest
possibl
benefit
treatment
abus
yet
test
clinic
set
nmda
inhibitor
exampl
block
develop
toler
also
exhibit
toxic
limit
valu
nitric
oxid
inhibitor
also
potenti
treatment
also
block
develop
depend
withdraw
symptom
reduc
antagonist
suggest
might
effect
treatment
addict
serotonin
releas
uptak
blocker
also
attenu
sign
withdraw
indic
could
becom
compon
treatment
gamma
hydroxybutyr
acid
ghb
suppress
withdraw
symptom
heroin
addict
methadonemaintain
subject
day
ghb
stop
patient
maintain
naloxon
advers
effect
ghb
may
use
least
short
term
report
withdraw
intens
invers
relat
pretreat
space
morphin
pertin
transit
acut
chronic
physic
depend
wide
space
interv
greater
danger
depend
singl
exposur
anoth
benefici
methodolog
find
newli
develop
enzym
immunoassay
enzymelink
immunoassay
elisa
detect
specif
antibodi
morphin
chronic
opiat
user
superior
test
offer
theoret
notion
presenc
circul
antibodi
specif
morphin
final
interest
studi
obes
woman
experienc
withdraw
symptom
treatment
naltrexon
suppress
eat
addict
exogen
opiat
specul
hyperact
endogen
opiat
system
requir
toler
normal
level
caution
concern
use
opiat
antagonist
treat
obes
suggest
eat
continu
interest
role
endogen
opiat
system
might
play
eat
past
gener
find
opiat
agonist
stimul
feed
opiat
antagonist
inhibit
although
disson
find
still
persist
need
delin
variabl
affect
action
linger
hope
knowledg
use
eat
disord
anorexia
nervosa
obes
although
limit
reinforc
idea
administr
morphin
consist
promot
eat
except
given
repeatedli
total
calor
intak
withdraw
chronic
morphin
reduc
intak
might
expect
avail
opiat
declin
anoth
agonist
damgo
increas
eat
agonist
dpen
enkephalin
agonist
howev
fit
typic
pattern
effect
eat
situat
although
stimul
anoth
dynorphin
fail
promot
feed
rather
inhibit
mix
agonistantagonist
butorphanol
increas
eat
indic
agonist
action
case
appear
opiat
mediat
eat
involv
mainten
rather
initi
eat
morphin
increas
speed
eat
latenc
eat
fooddepriv
rat
affect
neither
respons
conclud
u
k
receptor
involv
regul
feed
depriv
test
k
receptor
may
trigger
tast
food
may
sustain
feed
facilit
incent
reward
delay
develop
satiat
sever
area
brain
identifi
import
opiat
mediat
eat
damgo
dpen
inject
ventral
striatum
nucleu
accumben
anteroventromedi
striatum
stimul
eat
nondepriv
anim
although
amount
chang
vari
specif
area
structur
inject
region
also
involv
impuls
control
may
opiat
mechan
over
later
hypothalamu
previous
shown
mediat
tast
prefer
increas
consumpt
saccharin
inject
damgo
may
also
play
role
opiat
regul
eat
modif
effect
morphin
occur
sever
differ
agent
nitric
oxid
influenti
indic
find
inhibitor
suppress
morphineinduc
eat
fooddepriv
mice
larginin
darginin
potenti
morphin
promot
eat
role
ofdopamin
respons
also
suggest
chronic
amphetamin
increas
prophag
effect
rat
although
mechan
involv
clear
strain
differ
also
occur
feed
respons
morphin
lewi
rat
stimul
fischer
rat
differenti
consumpt
specif
macronutri
well
explan
effect
clear
small
differ
tissu
concentr
morphin
chang
endogen
opiat
system
occur
food
depriv
suggest
possibl
mechan
opiat
regul
eat
depriv
hypothalamu
rat
earli
first
day
depriv
depriv
also
increas
serum
corticosteron
decreas
dexamethason
suppress
adren
glucocorticoid
secret
indic
impair
hpa
axi
opiat
system
dynorphin
express
hypothalamu
show
complex
pattern
depriv
increas
supraopt
nucleu
retrochiasmat
chang
supraopt
nucleu
arcuat
nucleu
decreas
ventromedi
nucleu
dorsomedi
nucleu
paraventricular
nucleu
thu
permit
simpl
interpret
role
dynorphin
eat
work
field
focus
effect
opiat
antagonist
eat
typic
suppress
intak
wide
varieti
condit
antagonist
decreas
feed
satiat
anim
depriv
anim
palatabilityinduc
eat
hyperphagia
tail
pinchinduc
eat
highfatinduc
feed
electr
stimul
eat
number
differ
antagonist
produc
inhibit
includ
naloxon
antagonist
naltrexon
antagonist
norbinaltorphimin
irrevers
antagonist
antagonist
naloxonazin
antagonist
naltrindol
methyl
naloxonium
bromid
given
nucleu
accumben
phenylpiperidinebas
opiat
antagonist
like
u
antagonist
ctop
dphecystrydtrpornthrpenthrnhz
ctap
mix
agonistantagonist
nalbuphin
butorphanol
naltrindol
howev
fail
block
either
tail
pinchinduc
feed
neuropeptid
yinduc
eat
naltrexon
norbinaltorphimin
dalc
enkephalin
also
suppress
tail
pinchinduc
hyperphagia
naloxonazin
effect
feed
number
variabl
affect
opiat
mediat
deprivationinduc
eat
includ
dose
antagonist
age
gender
gonadectomi
produc
complex
interact
age
gender
gonadectomi
influenc
action
low
dose
naloxon
high
dose
shamoper
male
greater
agerel
genderrel
inhibit
eat
gonadectomi
young
age
also
increas
effect
high
dose
naloxon
highfatinduc
eat
potenc
naloxon
increas
shamoper
femal
function
age
decreas
shamoper
male
ovariectom
femal
function
age
clear
dissoci
base
motiv
consumpt
variabl
crucial
understand
phenomenon
signific
yet
delin
similarli
receptor
specif
rout
ofadministr
macronutri
eaten
interact
mean
find
total
sort
pretreat
milk
either
whole
skim
potenti
suppress
eat
naloxon
probabl
due
consequ
calor
intak
upregul
endogen
opiat
system
whole
milk
stronger
effect
skim
milk
despit
fact
equal
volum
consum
repeat
present
day
produc
toler
antagonist
maintain
abil
inhibit
intak
naltrexon
lost
effect
day
differ
antagonist
differenti
amount
upregul
opiat
system
serotonin
shown
alter
opiat
mediat
eat
somewhat
measur
opiat
antagonist
although
gener
serotonin
antagonist
methysergid
olson
olson
kastin
antagonist
minim
effect
naltrexon
inhibit
eat
ritanserin
bind
receptor
block
naltrexon
effect
suggest
receptorspecif
interact
opiat
system
serotonin
reuptak
inhibitor
fluoxetin
howev
affect
symptom
anorex
patient
even
though
increas
dynorphin
suggest
interact
system
disord
bulim
though
serotonin
dopamin
metabolit
correl
chang
cerebrospin
fluid
csf
indic
complex
relationship
among
system
dopamin
also
shown
affect
opiatemedi
eat
rat
although
action
situat
depend
antagonist
haloperidol
enhanc
naltrexon
inhibit
feed
agonist
quinpirol
enhanc
deprivationinduc
eat
clearli
delin
interact
neuropeptid
need
recent
year
interest
shift
opiat
modul
gross
chang
amount
food
consum
focu
differenti
effect
specif
macronutri
continu
infus
morphin
rat
produc
biphas
effect
reduc
carbohydr
intak
increas
fat
intak
first
day
revers
occur
termin
morphin
produc
decreas
rel
prefer
fat
eat
return
baselin
within
day
strain
differ
respons
acut
morphin
consumpt
carbohydr
increas
lewi
rat
fischer
rat
although
morphin
increas
fat
intak
equal
indic
may
genet
differ
prefer
macronutri
respons
opiat
manipul
effect
specif
eat
rat
prefer
highfat
diet
exhibit
analgesia
morphin
baselin
antinocicept
prefer
highcarbohydr
diet
modul
opiat
system
antagonist
also
demonstr
role
opiat
peptid
intak
macronutri
although
specif
manipul
sever
variabl
system
naltrexon
inhibit
consumpt
macronutri
hyperphagia
carbohydr
fat
food
depriv
central
administ
antagonist
attenu
intak
fat
condit
motiv
central
inhibit
eat
carbohydr
fat
situat
naloxonazin
suppress
depriv
none
k
antagonist
differenti
effect
macronutri
indic
opiat
mediat
probabl
tt
receptor
naltrexon
reduc
intak
simpl
maltos
dextrin
complex
sucros
carbohydr
kind
carbohydr
might
affect
opiat
system
opiat
also
shown
modul
tast
prefer
surpris
hedon
avers
properti
morphin
enhanc
palat
pleas
tast
seen
find
rat
increas
eat
sucros
alter
amount
quinineflavor
food
consum
damgo
increas
ingest
saccharin
dynorphin
reduc
suggest
receptorspecif
reaction
naloxon
reduc
deprivationinduc
intak
chocol
chip
cooki
prefer
normal
rat
chow
present
separ
occas
given
concurr
howev
differ
disappear
offer
avers
tast
highfib
chow
naloxon
decreas
intak
high
dose
indic
effect
antagonist
depend
palat
food
support
opiat
mediat
tast
came
find
immunoreact
tast
bud
rat
mice
guinea
pig
endogen
opiat
system
modul
consumpt
food
surpris
also
affect
bodi
weight
chronic
morphin
produc
weight
gain
rat
abstent
reduc
amount
expect
weight
gain
gain
associ
morphin
attenu
midazolam
unalt
nitric
oxid
synthesi
inhibitor
indic
opiat
interact
benzodiazepin
nitric
oxid
situat
support
role
opiat
system
regul
weight
came
report
opiat
antagonist
naloxon
ctop
reduc
weight
gain
rat
opiat
involv
control
weight
natur
look
opiat
system
etiolog
treatment
eat
disord
far
evid
encourag
although
effect
seen
studi
found
concentr
csf
plasma
reduc
patient
anorexia
nervosa
correl
bodi
mass
csf
howev
treatment
megestrol
acet
revers
decreas
affect
bodi
weight
bodi
mass
anoth
studi
found
differ
anorex
normal
individu
basal
plasma
correl
bodi
mass
respons
peptid
crh
blunt
anorex
rel
normal
may
play
yet
undelin
role
disord
similarli
dynorphin
suprachiasmat
hypothalam
nucleu
greater
anorex
given
treatment
consist
exercis
normal
weight
match
anorex
thu
depriv
exercis
differ
depriv
without
exercis
opiat
involv
complex
confus
appar
opiat
system
mediat
bulimia
csf
differ
rel
normal
find
obes
similar
anorexia
although
differ
basal
plasma
obes
either
abdomin
peripher
control
women
differenti
respons
inject
crf
abdomin
obes
show
greater
respons
two
group
differ
thu
abdomin
obes
may
increas
opiat
activ
dietari
obes
induc
sheep
increas
plasma
rel
lean
anim
potenti
inhibitori
effect
naloxon
eat
overweight
sheep
appear
alter
opiat
system
obes
rat
obes
induc
highfat
diet
latenc
tail
flick
respons
higher
control
indic
reduct
sensit
pain
consist
increas
activ
endogen
opiat
system
obes
support
notion
came
report
inject
ofnaltrexon
obes
woman
help
control
eat
produc
opiat
withdraw
symptom
possibl
hyperact
opiat
system
might
contribut
obes
respons
use
indic
opiat
modul
eat
morphin
increas
blood
glucos
glucagon
fed
fast
rat
effect
naloxon
revers
indic
opiat
control
morphin
increas
insulin
fed
fast
rat
action
block
naloxon
fed
one
physiolog
reaction
feed
seem
opiat
modifi
consumpt
food
alter
nocicept
basal
morphin
induc
basal
analgesia
potenti
corn
oil
morphin
analgesia
increas
highfat
diet
corn
oil
diet
effect
sweet
tast
howev
produc
contradictori
result
chronic
sucros
diet
facilit
morphin
analgesia
chronic
saccharin
attenu
possibl
differenti
nutrit
benefit
two
sweeten
might
respons
differ
neither
immedi
effect
chronic
naloxon
affect
bodi
weight
also
inhibit
stimul
corticosteron
suggest
interact
hormon
k
receptor
might
respons
weight
loss
hypothermia
induc
morphin
enhanc
saccharin
support
view
sweet
substanc
activ
endogen
opiat
system
individu
report
greater
normal
number
ill
also
report
limit
food
mobil
opiat
system
sweet
fat
bread
well
ill
opiat
drug
alcohol
indic
correl
opiat
system
ill
mechan
opiat
mediat
food
intak
postul
start
feed
initi
signal
produc
activ
k
receptor
therebi
induc
eat
eat
produc
circular
reaction
start
hedon
input
eat
activ
u
receptor
regul
kvp
open
close
turn
produc
reward
caus
eat
complet
circl
thu
k
u
receptor
involv
differ
place
eat
process
drink
interest
possibl
regul
drink
fluid
continu
declin
recent
year
much
work
done
year
involv
hypothes
relationship
endogen
opiat
system
consumpt
alcohol
opiat
influenc
intak
alcohol
drink
alter
opiat
system
although
exact
natur
connect
still
unclear
overal
pictur
opiat
mediat
drink
simpl
eat
conflict
find
opiat
agonist
antagonist
morphin
report
increas
drink
would
consist
effect
eat
suppress
drink
effect
depend
specif
condit
dose
understand
factor
low
dose
facilit
high
dose
inhibit
intak
fluid
specif
sodium
solut
sodiumdefici
rat
strain
differ
also
crucial
lewi
rat
exhibit
greater
respons
morphin
fischer
rat
although
effect
seen
system
inject
microinject
morphin
striatal
region
produc
effect
drink
agonist
damgo
stimul
eat
intact
satiat
rat
suppress
lesion
later
hypothalamu
indic
receptor
area
import
opiat
regul
drink
striatum
howev
appar
involv
neither
damgo
agonist
dpen
k
agonist
affect
drink
inject
directli
structur
dtlet
enkephalinthr
increas
respond
saccharin
solut
suggest
role
receptor
area
involv
k
receptor
receiv
mix
report
larg
dose
dynorphin
requir
effect
ingest
saccharin
inhibitori
intact
anim
later
hypothalam
lesion
drank
less
water
saccharin
solut
analogu
ofdynorphin
dakli
effect
respons
saccharin
microinject
striatum
alter
drink
lead
question
concern
involv
k
receptor
respons
howev
intak
high
concentr
sucros
facilit
low
concentr
inhibit
shamfeed
rat
hedon
properti
solut
consum
import
normal
rat
ip
suppress
drink
first
hour
action
affect
chronic
treatment
amphetamin
indic
interact
opiat
system
amphetamin
situat
find
naloxon
naltrexon
consist
antagonist
inhibit
drink
except
low
dose
naloxon
effect
decreas
intak
saccharin
maltos
dextrin
sodium
sodiumdefici
rat
sucros
thu
exhibit
much
gener
ontogeni
effect
howev
depend
mean
ingest
naloxon
effect
day
age
rat
pup
drank
beaker
floor
suppress
drink
day
age
continu
intraor
infus
anterior
sublingu
cathet
rout
administr
crucial
naltrexon
system
inject
inhibit
drink
induc
angiotensin
ii
hyperton
salin
central
naltrexon
reduc
angiotensin
iiinduc
intak
antagonist
produc
somewhat
situationspecif
result
depend
sourc
motiv
drink
antagonist
effect
consumpt
palat
saccharin
solut
although
inhibit
maltos
dextrin
induc
angiotensin
ii
hyperton
salin
indic
strong
role
receptor
z
antagonist
naloxonazin
alter
drink
condit
suppress
effect
probabl
mediat
receptor
receptor
mediat
slightli
differ
effect
antagonist
dalc
decreas
angiotensin
ifinduc
drink
dalc
ligand
naltrindol
slow
drink
saccharin
effect
maltos
dextrin
respons
hyperton
salin
k
antagonist
norbinaltorphimin
affect
intak
palat
substanc
saccharin
maltos
dextrin
reduc
induc
hyperton
salin
angiotensin
ii
suggest
k
receptor
mediat
mainten
physiolog
homeostasi
tast
drink
milk
appear
produc
indirect
activ
k
receptor
dopamin
mediat
decreas
milk
rat
fetal
facial
wipe
tactil
probe
inhibit
norbinaltorphimin
antagonist
either
agonist
mimick
milk
effect
reduc
wipe
respons
action
block
appropri
antagonist
intak
sucros
lower
concentr
dorsal
ventral
hypothalamu
spontan
hypertens
rat
normal
rat
endogen
opiat
system
activ
sucros
special
popul
much
research
drink
center
around
role
opiat
system
consumpt
alcohol
appear
upregul
opiat
system
ingest
ethanol
includ
increas
receptor
express
vitro
longterm
treatment
ethanol
prodynorphin
mrna
brain
ethanolf
mice
administr
alcohol
rat
rais
concentr
hypothalamu
hippocampu
cortex
concurr
inject
ethanol
ro
benzodiazepin
invers
agonist
block
rise
hypothalamu
ethanol
flumazenil
benzodiazepin
antagonist
attenu
hippocampu
ethanol
benzodiazepin
agonist
diazepam
alter
suggest
effect
mediat
acidbenzodiazepin
receptor
stimul
releas
hypothalamu
transitori
spike
rapidli
return
baselin
within
min
ifa
second
inject
ethanol
given
within
min
first
one
increas
endorphin
seen
suggest
temporari
toler
ethanol
effect
occur
mice
bred
prefer
ethanol
find
avers
former
react
strongli
indic
genet
differ
suscept
alcohol
support
idea
came
find
also
strain
differ
opiat
activ
mice
select
bred
resist
sensit
ethanolinduc
hypothermia
u
bind
increas
frontal
cortex
resist
effect
manipul
opiat
system
administr
opiat
agonist
antagonist
effect
intak
alcohol
provid
evid
role
opiat
system
respons
morphin
increas
drink
ethanol
blood
alcohol
level
rat
antagonist
gener
suppress
consumpt
receptor
involv
clear
naloxon
ctop
inhibit
drink
ethanol
question
whether
receptor
mediat
respons
similarli
role
receptor
undecid
naltrexon
naltrindol
reduc
intak
alcohol
ici
least
male
femal
drink
could
measur
antagonist
produc
confound
motor
dysfunct
perhap
receptor
subtyp
need
investig
delin
specif
action
like
simpl
direct
modul
effect
opiat
system
rather
interact
system
support
idea
came
find
naltrindol
infus
nucleu
accumben
rat
block
increas
extracellular
dopamin
elicit
ethanol
deltorphin
ii
similarli
local
appli
ethanol
increas
dopamin
releas
serotonin
nucleu
accumben
effect
revers
naltrexon
suggest
opiat
system
mediat
reward
ethanol
naloxon
also
inhibit
suppress
amplitud
excitatori
postsynapt
potenti
evok
ethanol
nucleu
accumben
indic
ethanol
might
act
opiat
mechan
although
appear
evid
idea
still
clinic
find
indic
may
use
tool
treatment
alcohol
recent
year
interest
opiat
modul
gastrointestin
gi
function
dwindl
consider
report
previou
year
opiat
agonist
includ
morphin
metenkephalin
damgo
dpdpe
slow
gastric
motil
correl
durat
inhibit
affin
agonist
receptor
acupuncturelik
stimul
abdomen
anesthet
rat
suppress
gastric
motil
probabl
nonopi
mechan
naloxon
effect
u
agonist
loperamid
enkephalinas
inhibitor
acetorphan
rapidli
similarli
reduc
diarrhea
presum
infecti
origin
human
wellknown
action
opiat
acetorphan
reduc
abdomin
distens
rapidli
produc
less
reactiv
constip
suggest
possibl
clinic
benefit
gi
transit
liquid
meal
human
howev
unalt
naloxon
either
normal
condit
mild
exercis
acceler
transit
time
indic
lack
mediat
opiat
system
respons
opiat
agonist
contradictorili
also
produc
intestin
hyperact
chick
relat
affin
ligand
produc
duoden
hyperact
propag
naloxon
lengthen
durat
migrat
motor
complex
indic
involv
opiat
system
respons
jejun
excitatori
motor
respons
anesthet
cat
also
produc
morphin
vagal
nerv
stimul
approxim
equal
efficaci
contractil
respons
consist
increas
tone
phasic
activ
excitatori
inhibitori
potenti
isol
muscl
strip
pylor
sphincter
inhibit
metenkephalin
dadl
effect
rest
potenti
slowwav
activ
suggest
effect
junction
potenti
direct
effect
smooth
muscl
cell
guinea
pig
ileum
frequent
use
prepar
studi
effect
opiat
gi
tissu
agonist
typic
inhibit
electr
stimul
contract
observ
report
effect
develop
toler
function
concentr
morphin
exposur
time
morphin
expect
chronic
opiat
applic
naloxon
norbinaltorphimin
stimul
contract
action
receptor
specif
norbinaltorphimin
work
morphin
naloxon
produc
contract
low
dose
agonist
wash
prepar
opiat
agonist
antagonist
superfus
longitudin
circular
muscl
strip
human
sigmoid
colon
neither
dynorphin
alter
spontan
contract
dramat
reduc
amplitud
contract
elicit
electr
stimul
effect
k
ligand
block
k
antagonist
norbinaltorphimin
antagonist
ici
indic
involv
k
receptor
action
consciou
rat
enkephalinas
inhibitor
acetorphan
increas
percentag
long
spike
burst
go
distal
colon
occur
typic
feed
reinforc
increas
induc
feed
indic
role
opiat
system
electromyograph
activ
colon
idea
support
naloxon
revers
action
respons
appear
interact
opiat
system
gi
function
nonadrenerg
noncholinerg
mechan
suggest
modul
opiat
activ
circular
muscl
small
intestin
potenc
effect
morphin
equival
vagal
nerv
stimul
gi
system
goldfish
metenkephalin
counteract
effect
serotonin
indic
involv
system
respons
probabl
opiat
mediat
nitric
aciddepend
neurotransmiss
either
metenkephalin
dadl
suppress
portion
inhibitori
junction
potenti
sensit
arginin
analogu
opiat
system
seem
play
role
muscular
electr
activ
gi
tract
also
secret
dermorphin
increas
basal
gastric
acid
secret
although
neither
dadl
dynorphin
alter
opiat
modul
gastric
acid
secret
elicit
depend
upon
prepar
studi
dog
gastric
fistula
dadl
effect
inhibitori
heidenhain
pouch
dermorphin
activ
agonist
stimul
secret
pentagastrinstimul
acid
secret
increas
dermorphin
block
dadl
dog
fistula
dog
pouch
increas
dermorphin
dadl
conclud
peripher
receptor
mediat
excitatori
effect
receptor
produc
mainli
inhibitori
one
k
receptor
seem
involv
opiat
system
might
also
affect
gi
activ
enkephalin
releas
longitudin
myenter
tissu
electr
stimul
vivo
peristalsi
occur
enkephalin
may
releas
suppress
movement
small
intestin
thorac
splanchnic
nerv
ligat
decreas
enkephalinlik
immunoreact
gastroduoden
region
suggest
peptid
may
involv
intestin
motil
although
chang
concentr
ileocolon
region
speci
previous
studi
found
opiat
activ
gut
wide
varieti
insect
reaction
antisera
metenkephalin
leuenkephalin
gut
innerv
endocrin
cell
midgut
suggest
possibl
opiat
control
function
enkephalinlik
immunoreact
found
teleost
speci
tilapia
oreochromi
mosambicu
goldfish
carassiu
aurata
mucosa
endocrin
cell
circular
layer
fiber
myenter
plexu
fiber
longitudin
muscl
layer
fiber
like
physiolog
effect
similar
speci
studi
past
year
research
protect
effect
opiat
ulcer
studi
damgo
dpdpe
shown
reduc
gastric
lesion
rat
subject
coldrestraint
stress
naloxon
block
effect
agonist
naltrindol
revers
action
dpdpe
nevertheless
u
receptor
seem
involv
respons
patient
chronic
ulcer
diseas
addit
strongli
enhanc
immun
respons
phytohemagglutinin
signific
find
clear
relat
treatment
ulcer
suggest
opiat
system
might
mediat
effect
stressinduc
disord
immun
system
morphin
known
produc
nausea
vomit
problem
clinic
use
inject
methylnaltrexon
block
morphineinduc
emesi
alter
analges
potenc
indic
elimin
unwant
side
effect
without
reduc
primari
function
littl
work
done
opiat
mediat
hepat
function
increas
metenkephalin
rat
acut
cholestat
hepat
sourc
rise
identifi
sympathet
nervou
system
rather
adren
gland
repeat
administr
naltrexon
found
alter
liver
enzym
test
sgot
sgpt
clear
antagonist
unwant
side
effect
liver
use
treatment
disord
autism
howev
increas
interest
possibl
opiat
involv
renal
function
administr
opiat
agonist
produc
conflict
result
although
much
inconsist
could
account
kind
receptor
stimul
u
agonist
morphin
metabolit
reduc
urin
output
although
increas
naloxon
revers
effect
three
thought
action
opiat
receptor
found
bind
receptor
dermorphin
anoth
u
agonist
given
icv
iv
produc
opposit
effect
increas
urin
flow
u
antagonist
block
effect
dermorphin
howev
effect
effect
renal
plasma
flow
glomerularfiltr
rat
increas
effer
renal
sympathet
nerv
activ
action
mediat
central
chang
renal
outflow
kidney
hemodynam
activ
differ
subtyp
might
respons
differ
k
receptor
appear
effect
determin
site
administr
microinject
dynorphin
dakli
tyrglyglypheleuargargileargproargleuarggli
paraventricular
nucleu
produc
antidiuret
effect
dynorphin
supraopt
nucleu
action
ofdynorphin
revers
atropin
timolol
site
naloxon
paraventricular
nucleu
conclud
action
supraopt
nucleu
opiat
mediat
site
involv
adrenerg
cholinerg
mechan
possibl
dakli
paraventricular
nucleu
also
produc
nonopi
effect
dakli
inhibit
naloxon
might
respond
dose
use
system
icv
k
agonist
diuret
effect
rat
produc
norbinaltorphiminerevers
increas
urin
output
renal
sympathet
nerv
activ
although
dermorphin
stimul
urin
output
reduc
sodium
excret
least
central
administ
indic
k
mediat
antinatriuret
respons
cyclazocin
mix
k
agonist
three
k
agonist
brl
brl
brl
also
stimul
diuresi
depend
abil
cross
bloodbrain
barrier
serotonin
antagonist
metergolin
suppress
increas
urin
due
cyclazocin
suggest
serotonin
might
involv
complex
mechan
k
agonistinduc
diuresi
effect
microinject
dadl
paraventricular
nucleu
supraopt
nucleu
similar
dynorphin
former
produc
opiatemedi
effect
interact
opiat
adrenerg
cholinerg
mechan
site
naloxon
alon
naltrindol
naloxoneprecipit
withdraw
butorphanol
effect
urin
output
lead
question
concern
involv
opiat
system
normal
regul
opiatemedi
renal
function
might
relat
cardiovascular
activ
well
rat
bred
possess
renal
hypertens
appear
increas
sensit
opiat
respons
might
occur
interact
angiotensin
ii
brain
addit
kidney
damag
due
reperfus
hemorrhag
inhibit
naloxon
suggest
endogen
opiat
might
respons
tissu
damag
situat
research
opiat
modul
mental
ill
mood
continu
declin
recent
year
perhap
due
lack
promis
find
still
interest
opiat
involv
depress
autism
area
overlook
part
depress
patient
baselin
lower
normal
control
may
due
part
confound
age
advanc
age
produc
lower
particularli
women
depress
found
frequent
older
popul
appear
abnorm
function
hpa
axi
depress
patient
indic
nonsuppress
sever
test
infus
ofcortisol
produc
less
releas
opiat
peptid
depress
individu
normal
control
suppress
flendorphin
dexamethason
found
patient
other
increas
age
potenti
likelihood
dexamethason
would
suppress
flendorphin
support
idea
age
confound
factor
inhibit
cortisol
synthesi
metyrapon
increas
test
concentr
endorphin
control
support
notion
impair
hpa
respons
disord
within
patient
popul
howev
differ
melanchol
individu
minor
depress
either
baselin
plasma
flendorphin
respons
acth
positron
emiss
tomographi
pet
singl
photon
emiss
tomographi
spect
found
increas
u
receptor
depress
patient
frontal
cortex
tempor
cortex
symptom
sever
enough
commit
suicid
retroact
find
death
indic
increas
magnitud
sever
fold
normal
k
ligand
pet
imag
avail
determin
could
made
chang
depress
anim
model
depress
learn
helpless
modifi
manipul
opiat
system
two
inhibitor
ofenkephalin
catabol
rb
rb
produc
imipraminelik
antidepress
effect
measur
decreas
escap
failur
naloxon
increas
helpless
antagon
effect
r
r
indic
opiat
natur
effect
find
might
clinic
signific
therapi
depress
similarli
autism
might
medit
least
part
endogen
opiat
system
manipul
might
use
treatment
baselin
concentr
flendorphin
lower
autist
children
normal
strong
correl
peptid
level
sever
stereotypi
although
naltrexon
affect
measur
ofendorphin
shortterm
administr
haloperidol
therapi
increas
longterm
use
drug
howev
lower
concentr
peptid
remov
produc
increas
endorphin
indic
disturb
opiat
system
similarli
naltrexon
reduc
number
intens
symptom
autism
given
acut
chronic
symptom
respond
better
other
hyperact
nonmeaning
vocal
decreas
talk
presenc
other
chang
indirect
support
disturb
normal
opiat
function
autist
came
find
subgroup
patient
normal
insensit
pain
signific
hyperalges
respons
acut
naltrexon
opiat
system
may
also
play
role
posttraumat
stress
disord
ptsd
half
ptsd
patient
increas
hormon
respons
naloxon
endocrin
chang
correl
sever
ptsd
symptom
standard
psychiatr
ill
measur
psycholog
test
subgroup
possibl
opiatemedi
hypersensit
hpa
axi
n
vitro
studi
blood
cell
patient
ptsd
reveal
alter
immun
function
respons
opiat
metenkephalin
increas
natur
killer
cell
activ
patient
symptom
normal
disord
tenuous
link
opiat
system
selfinjuri
behavior
reduc
naloxon
naltrexon
patient
characterist
distinguish
respond
nonrespond
determin
possibl
mechan
explain
decreas
occur
includ
suggest
selfinjuri
behavior
might
caus
releas
endogen
opiat
would
reward
would
dull
pain
make
behavior
less
avers
schizophren
patient
nalmefen
longlast
antagonist
activ
k
u
receptor
potenti
benefit
neurolept
suggest
manipul
opiat
system
might
clinic
valu
neg
correl
concentr
csf
dissoci
symptom
bulim
patient
indic
disturb
opiat
peptid
might
mediat
experi
subpopul
individu
may
also
relationship
endogen
opiat
hypochondria
peopl
self
report
ill
also
consum
fewer
food
mobil
opiat
system
thu
possibl
caus
underact
mood
modul
endogen
opiat
anxieti
measur
buri
novel
object
rat
correl
decreas
plasma
accord
find
administr
reduc
anxieti
elev
plu
maze
although
affect
anxieti
open
field
maze
u
agonist
hydromorphon
mix
agonistantagonist
pentazocin
produc
euphoria
umedi
subject
effect
revers
naltrexon
indic
opiat
natur
withdraw
methadon
mainten
produc
increas
symptom
dysphoria
insomnia
somat
complaint
lead
conclus
develop
organ
mood
syndrom
common
occurr
patient
undergo
slow
detox
methadon
relat
chang
occur
endogen
opiat
system
recent
year
increas
interest
role
opiat
system
mediat
learn
memori
well
reinforc
properti
opiat
except
differ
kind
learn
respond
differenti
opiat
modul
mani
methodolog
variabl
alter
action
within
paradigm
gener
effect
made
learn
task
must
review
separ
howev
mani
studi
report
agonist
inhibit
learn
antagonist
facilit
involv
opiat
system
behavior
establish
classic
pavlovian
condit
receiv
increas
attent
especi
condit
place
prefer
avers
acquir
pair
distinct
environ
drug
environ
develop
pleasur
neg
properti
depend
whether
drug
reward
avers
effect
varieti
opiat
agonist
use
context
includ
morphin
one
metabolit
damgo
stabl
dynorphin
deriv
dpdpe
buprenorphin
inhibitor
ofenkephalindegrad
enzym
act
like
antagonist
situat
agonist
appar
reward
properti
prefer
develop
area
associ
although
except
base
specif
manipul
made
site
administr
one
crucial
variabl
damgo
produc
place
prefer
microinject
ventral
tegment
area
administ
later
hypothalamu
nucleu
accumben
medial
prefront
cortex
substantia
nigra
k
agonist
howev
induc
place
avers
introduc
area
except
substantia
nigra
like
z
agonist
damgo
agonist
dpdpe
effect
similarli
neither
k
ligand
alter
prefer
inject
nucleu
caudatusputamen
system
administr
morphin
produc
place
prefer
induc
place
avers
thu
effect
k
agonist
avers
agonist
pleasur
pretreat
block
morphineinduc
place
prefer
action
block
norbinaltorphimin
support
avers
natur
k
agonist
place
prefer
morphin
also
suppress
antagonist
antagonist
naloxonazin
suggest
effect
might
mediat
receptor
might
interact
di
receptor
antagonist
inhibit
morphin
place
prefer
thu
implic
dopaminerg
system
well
opiat
system
immunosuppress
cyclosporin
also
block
prefer
morphineassoci
place
although
involv
immun
system
morphin
reward
clear
enkephalinas
inhibitor
rb
produc
place
prefer
indic
reinforc
properti
antinocicept
potenc
clinic
potenti
nonaddict
analges
suggest
opiat
antagonist
alon
includ
naloxon
naltrexon
develop
place
avers
morphinedepend
rat
withdraw
produc
place
avers
chamber
associ
antagonist
propranolol
atenolol
attenu
avers
suggest
agent
might
effect
treatment
opiat
addict
avers
withdraw
morphinedepend
rat
also
associ
complex
condit
stimulu
naloxon
pair
present
combin
distinct
odor
tone
tone
light
antagonist
complex
stimulu
present
independ
differ
time
indic
contigu
stimuli
necessari
learn
condit
tast
prefer
avers
similar
place
prefer
avers
distinct
tast
associ
drug
might
take
affect
properti
drug
morphin
pair
particular
tast
produc
tast
avers
wide
rang
dose
delay
morphin
h
tast
elimin
effect
despit
typic
find
postpon
avers
stimulu
period
time
affect
condit
antagonist
includ
naloxon
k
antagonist
mr
mix
k
antagonist
nalorphin
buprenorphin
fail
produc
condit
tast
avers
even
high
dose
multipl
trial
usual
singl
trial
necessari
tast
avers
develop
somewhat
complex
form
condit
tast
avers
also
use
anim
pretreat
opiat
given
opportun
consum
distinct
tast
follow
nauseainduc
inject
lithium
chlorid
later
intak
solut
measur
inject
morphin
rel
control
given
neither
morphin
avers
nausea
consumpt
solut
decreas
morphin
indic
opiat
develop
neg
qualiti
result
train
gener
test
buprenorphin
substitut
morphin
revers
partial
true
buprenorphin
gener
mr
diprenorphin
latter
substitut
morphin
action
buprenorphin
situat
probabl
receptor
naltrexon
reduc
strain
differ
found
obes
lean
mice
tast
avers
frequent
use
saccharin
lithium
chlorid
pair
suggest
opiat
involv
similar
phenomenon
condit
odor
prefer
rat
receiv
one
odor
pair
morphin
anoth
one
pair
salin
rat
spent
time
morphinerel
odor
low
dose
use
less
time
high
dose
pair
high
dose
morphin
odor
also
produc
condit
analgesia
odor
reduc
nocicept
daili
inject
naloxon
tyrmifi
hot
plate
test
pain
produc
hypoalgesia
found
chronic
administr
antagonist
alon
indic
analgesia
involv
avers
condit
perhap
associ
apparatu
condit
analgesia
heat
stressor
attenu
morphin
enhanc
naloxon
inject
icv
iv
opiat
mediat
appear
supraspin
opiat
system
seem
involv
condit
emot
respons
paradigm
avers
acquir
stimulu
measur
abil
suppress
respond
anoth
situat
morphin
pair
shock
produc
condit
suppress
drink
morphin
later
inject
rel
drink
anim
receiv
pair
indic
morphin
act
condit
stimulu
naloxoneprecipit
withdraw
morphinedepend
rat
pair
distinct
condit
stimulu
later
stimulu
present
anim
respond
oper
chamber
respond
disrupt
indic
stimulu
acquir
avers
properti
rat
lesion
amygdala
less
disrupt
suggest
lesion
interf
learn
opiat
use
uncondit
condit
stimuli
classic
condit
also
agent
modifi
condit
rat
given
appetit
classic
condit
influenc
morphin
agonist
increas
magnitud
condit
dosedepend
way
contrari
mani
find
opiat
interfer
learn
antagonist
conflict
effect
depend
task
variabl
use
naloxon
enhanc
condit
fear
chamber
rat
shock
fear
tone
pair
shock
quaternari
naloxon
ctop
naloxon
quaternari
form
ctop
also
delay
extinct
howev
naloxon
ctop
norbinaltorphimin
interf
retent
condit
reduct
facial
wipe
sucros
pair
sucros
milk
normal
produc
respons
fetal
rat
suggest
receptor
k
one
involv
task
studi
crucial
opiat
mediat
paradigm
oper
condit
studi
much
attent
paid
inhibitori
avoid
task
typic
involv
present
noxiou
stimulu
consequ
specif
respons
distinct
environ
delay
period
often
day
return
environ
determin
latenc
make
respons
test
retent
avers
event
memori
good
respons
made
opiat
agonist
usual
impair
retent
respons
made
soon
reintroduct
apparatu
antagonist
facilit
memori
found
caus
morphin
metenkephalin
leuenkephalin
dynorphin
novel
dermorphin
tapa
howev
except
gener
rule
damgo
metenkephalin
effect
case
dynorphin
olson
olson
kastin
actual
improv
retent
anoth
naloxon
facilit
memori
expect
paradigm
specif
manipul
made
import
determin
outcom
metenkephalin
inject
medial
hyperstriatum
produc
amnesia
administ
lobu
parolfactoriu
effect
chick
train
peckavoid
task
situat
microinject
damgo
medial
hyperstriatum
also
fail
alter
retent
inject
ofdynorphin
area
impair
memori
suggest
structur
brain
effect
receptor
specif
studi
opiat
given
train
could
affect
result
found
comparison
preand
posttrain
inject
tapa
although
inject
time
inhibit
retent
given
train
produc
stronger
effect
age
anim
may
also
import
morphin
endogen
antiopi
combin
effect
rat
pup
first
week
life
wherea
morphin
reduc
retent
older
anim
chick
lower
dose
dynorphin
effect
old
chick
old
chick
indic
loss
sensit
least
area
brain
inject
made
intermedi
medial
hyperstfiatum
higher
dose
effect
age
invers
relationship
exist
endogen
opiat
system
dopamin
system
impair
memori
produc
morphin
potenti
antagonist
antagon
agonist
vagotomi
elimin
disrupt
effect
leuenkephalin
although
mechan
involv
clear
opiat
demonstr
modifi
amnest
effect
sever
manipul
includ
lesion
basal
forebrain
use
cholinerg
neurotoxin
iboten
acid
train
dynorphin
increas
retent
thu
revers
impair
transient
cerebr
ischemia
produc
mark
memori
dysfunct
dynorphin
prevent
disrupt
effect
peptid
revers
norbinaltorphimin
suggest
mediat
k
receptor
benefici
reaction
facilit
memori
posttrain
inject
substanc
p
modifi
naloxon
statedepend
fashion
naloxon
given
train
naloxon
potenti
improv
substanc
p
given
train
antagonist
inhibit
effect
differenti
mechan
statedepend
action
clear
activ
avoid
like
inhibitori
avoid
modifi
opiat
lever
press
postpon
shock
reduc
agonist
morphin
fentanyl
methadon
sidman
avoid
base
passag
time
sinc
last
shock
unaffect
suggest
taskspecif
effect
k
agonist
produc
variabl
effect
low
dose
nonselect
decreas
respond
gener
high
dose
indic
k
receptor
play
role
timeout
lever
press
typic
antagonist
naloxon
increas
retent
tbot
shock
avoid
tmaze
facilit
disappear
senesc
indic
chang
endogen
opiat
system
age
spontan
altern
task
measur
work
memori
anim
must
rememb
last
respons
go
differ
direct
next
respons
damgo
interf
perform
task
effect
revers
dynorphin
also
revers
action
damgo
action
block
norbinaltorphimin
indic
u
k
receptor
opposit
effect
work
memori
support
facilit
k
agonist
task
came
report
dynorphin
reduc
amnesia
transient
cerebr
ischemia
dynorphin
revers
impair
induc
scopolamin
likewis
perform
elev
plu
maze
improv
inject
dynorphin
damgo
interf
provid
evid
enhanc
memori
k
agonist
interfer
agonist
u
agonist
morphin
sufentanil
also
disrupt
perform
morri
water
maze
effect
morphin
depend
time
inject
howev
pretrain
posttrain
inject
effect
atyp
find
dynorphin
inhibit
learn
maze
perhap
site
inject
hippocampu
naloxon
facilit
learn
task
like
morphin
effect
given
train
pretrain
administr
endogen
antiopi
neuropeptid
ff
also
produc
margin
improv
learn
antiserum
inhibit
suggest
involv
opiat
system
spatial
acquisit
appetit
discrimin
learn
task
dynorphin
disrupt
effect
peck
avoid
young
chick
dosedepend
action
morphin
reduc
perform
visual
discrimin
task
involv
dimens
wavelength
lumin
pigeon
opiat
decreas
sensit
dimens
lower
control
lumin
affect
learn
also
sensori
process
interfer
revers
naloxon
suggest
opiat
modul
physiolog
evid
role
opiat
system
oper
instrument
condit
came
find
train
inhibitori
avoid
task
increas
concentr
metenkephalin
area
forebrain
chick
area
similarli
dynorphin
elev
age
rat
deficit
place
learn
normal
without
deficit
provid
indirect
support
idea
train
passiv
avoid
chick
increas
bind
area
forebrain
decreas
bind
area
chang
found
u
k
bind
suggest
receptor
might
mediat
kind
learn
opiat
system
modul
learn
opiat
agonist
antagonist
use
discrimin
stimuli
sd
subject
properti
indic
kind
respons
appropri
typic
form
learn
drug
becom
associ
one
respons
absenc
anoth
drug
test
abil
substitut
origin
one
produc
respons
number
opiat
agonist
use
sd
includ
morphin
bremazocin
fentanyl
buprenorphin
nalbuphin
among
antagonist
success
becom
sd
naloxon
naltrexon
nalorphin
threechoic
discrimin
also
learn
morphin
naloxon
placebo
anoth
naltrexon
salin
establish
pigeon
given
chronic
naloxon
abl
block
sd
effect
morphin
naltrexon
antagon
nalbuphin
naltrindol
revers
confirm
opiat
natur
substanc
test
high
dose
nalbuphin
abl
substitut
morphin
bremazocin
low
dose
nalbuphin
naloxon
fail
bremazocin
also
substitut
howev
morphin
abl
produc
amphetamineappropri
respond
indic
similar
properti
two
acut
toler
morphin
reduc
abil
nalbuphin
induc
morphineappropri
respond
none
three
antagonist
affect
sd
potenc
morphin
serotonin
involv
subject
properti
morphin
morphin
substitut
nalorphin
naloxon
naltrexon
suggest
nalorphin
umedi
agonist
properti
similarli
buprenorphinedepend
anim
buprenorphin
gener
morphin
k
antagonist
mr
indic
drug
act
like
u
agonist
situat
likewis
u
agonist
includ
morphin
etorphin
fentanyl
nalorphin
buprenorphin
substitut
nalbuphin
k
agonist
ethylketocyclazocin
nonopi
dpentazocin
damphetamin
ketamin
also
fail
gener
nalbuphin
naltrexon
produc
salineappropri
respond
provid
evid
activ
differenti
efficaci
drug
receptor
also
demonstr
test
gener
discrimin
learn
high
dose
fentanyl
morphin
substitut
complet
number
agent
substitut
consider
complet
butorphanol
buprenorphin
ethylketocyclazocin
ketocyclazocin
proxorphan
pentazocin
metazocin
other
substitut
littl
nalbuphin
nalorphin
cyclorphan
cyclazocin
nalli
normetazocin
levallorphan
low
dose
substitut
complet
gener
test
spiradolin
bremazocin
substitut
easili
levallorphan
nalbuphin
nalorphin
quacazocin
produc
naltrexoneappropri
respond
threeway
discrimin
naltrexon
salin
pigeon
get
chronic
morphin
substitut
either
naltrexon
chronic
stop
salin
produc
respond
salin
key
naltrexon
key
indic
depend
gener
nonopi
phencyclidin
serotonerg
compound
although
attenu
effect
spiradolin
suggest
serotonin
releas
import
compon
sd
effect
k
agonist
suffici
alon
mimic
bselect
agonist
dplpe
lpen
enkephalin
fulli
gener
cocain
cue
rat
effect
almost
complet
block
antagonist
naltrindol
agonist
damgo
substitut
cocain
suggest
cocain
mediat
b
receptor
morphin
block
discrimin
properti
cholecystokinin
naloxon
potenti
suggest
opiat
system
might
mediat
effect
subject
properti
opiat
use
discrimin
stimuli
also
reward
avers
valu
typic
test
term
modul
respond
reinforc
intracrani
selfstimul
icss
acut
inject
morphin
potenti
reward
effect
icss
rat
either
chang
slight
toler
effect
chronic
morphin
naloxoneprecipit
withdraw
howev
greatli
increas
threshold
icss
indic
depend
develop
morphin
potenti
abil
nicotin
increas
reinforc
valu
icss
rat
suggest
substrat
support
reinforc
morphin
reward
also
support
nicotin
chang
icss
produc
damgo
vari
placement
inject
peptid
inject
rostral
ventral
pallidum
reduc
reward
valu
caudal
ventral
pallidum
enhanc
appear
receptor
well
one
mediat
reinforc
intraaccumben
inject
dpdpe
lower
threshold
icss
thu
potenti
medial
forebrain
bundl
howev
b
antagonist
naltrindol
effect
respond
icss
suggest
area
brain
affect
crucial
effect
later
hypothalamu
naloxon
revers
enhanc
icss
produc
restrict
ot
food
periforn
placement
affect
placement
hunger
interact
reward
electr
stimul
brain
electr
stimul
ot
later
hypothalamu
also
induc
eat
microinject
k
antagonist
norbinaltorphimin
region
block
effect
antagonist
effect
selfstimul
absenc
food
ie
icss
howev
opiat
mediat
effect
seem
complex
confound
mechan
involv
yet
understood
opiat
mediat
kind
reward
besid
associ
icss
respond
food
increas
mix
agonistantagonist
butorphanol
shorten
latenc
start
respond
although
time
complet
fix
ratio
reward
affect
find
contrast
opiat
alfentanil
fentanyl
ethylketocyclazocin
reduc
respond
rate
food
perhap
differ
result
associ
mix
natur
butorphanol
respond
saccharin
nondepriv
rat
increas
damgo
dtlet
dynorphin
analogu
dakli
differenti
reward
satisfact
hunger
oppos
obtain
palat
tast
might
explain
find
heroin
use
reinforc
travers
alley
rat
reduc
latenc
start
run
reach
goal
suggest
heroin
reward
one
trial
per
day
rat
ever
run
influenc
drug
would
confound
experi
morphin
alfentanil
shown
impair
abil
process
inform
human
selfadministr
opiat
agonist
studi
anoth
way
assess
reward
properti
anim
quickli
learn
respond
receiv
inject
opiat
includ
morphin
especi
heroin
selfadministr
rate
morphin
posit
correl
previou
exposur
morphin
suggest
develop
toler
progress
ratio
schedul
selfadministr
heroin
design
restrict
intak
minim
depend
final
rate
respond
stabl
increas
chronic
reinforc
schedul
effect
prevent
depend
naltrexon
reduc
final
rate
respond
suggest
antagonist
attenu
reinforc
receiv
heroin
respond
howev
increas
naloxonazin
naltrindol
norbinaltorphimin
typic
method
selfadministr
indic
schedul
reinforc
crucial
result
addit
studi
demonstr
u
receptor
involv
selfadministr
subtyp
b
receptor
k
receptor
involv
lesion
pedunculopontin
nucleu
thought
mediat
opiat
reward
reduc
selfadministr
heroin
indic
heroin
must
reward
lesion
provid
support
import
nucleu
reinforc
properti
opiat
opiat
mediat
one
simplest
form
learn
habitu
although
find
conflict
two
speci
crab
respond
differenti
opiat
modul
one
speci
habitu
inhibit
morphin
facilit
naloxon
speci
unrespons
either
antagonist
includ
naloxon
ctop
norbinaltorphimin
combin
ctop
norbinaltorphimin
fail
alter
habitu
naloxon
norbinaltorphimin
increas
dishabitu
produc
present
novel
stimulu
habitu
origin
one
indic
slight
role
endogen
opiat
respons
although
natur
unclear
respons
novel
stimulu
chang
express
ofdynorphin
b
hippocampu
direct
chang
depend
strain
rat
apomorphinesuscept
anim
decreas
peptid
unsuscept
one
increas
respons
dynorphin
b
twoway
avoid
greater
unsuscept
one
thu
provid
addit
evid
interact
opiat
system
dopamin
learn
task
interest
possibl
role
opiat
system
cardiovascular
function
high
decreas
somewhat
may
part
due
lack
consist
previou
work
thu
allow
gener
drawn
cardiovascular
respons
opiat
mediat
highli
suscept
influenc
experiment
manipul
well
respons
measur
contribut
conflict
result
earli
studi
appear
whether
anim
consciou
anesthet
crucial
variabl
account
discrep
current
observ
mean
arteri
pressur
rais
metenkephalin
acut
hypotens
induc
isoproterenol
sodium
nitroprussid
enkephalin
produc
depressor
effect
indic
hemodynam
respons
peptid
alter
acut
manipul
blood
pressur
extent
receptor
type
activ
import
agonist
tend
reduc
blood
pressur
although
without
except
morphin
damgo
alfentanil
remifentanil
lower
situat
hydromorphon
morphin
rais
dermorphin
effect
singl
pressor
effect
morphin
spinal
rat
transient
special
condit
requir
increas
blood
pressur
hydromorphon
observ
human
substanc
abus
also
atyp
popul
kind
studi
inconsist
cardiovascular
respons
also
found
administr
k
agonist
half
studi
report
hypotens
half
find
effect
among
produc
depressor
effect
dynorphin
effect
site
inject
affect
result
icv
administr
alter
blood
pressur
iv
inject
microinject
hippocampu
reduc
likewis
icv
administr
dynorphin
reduc
blood
pressur
microinject
nucleu
solitari
tract
effect
similarli
effect
agonist
highli
variabl
produc
hypotens
chang
dadl
produc
hypertens
dpdpe
dadl
rais
systol
pressur
administ
epicardi
ganglia
effect
microinject
supraopt
nucleu
paraventricular
nucleu
site
inject
crucial
agonist
mix
agonistantagonist
pentazocin
also
pressor
effect
vagotomi
affect
rise
blood
pressur
due
dpdpe
decreas
pressur
due
attenu
hypotens
caus
morphin
damgo
suggest
vagu
interact
u
agonist
howev
vagotomi
block
abil
naloxon
revers
cardiovascular
effect
acut
morphin
even
produc
overshoot
suggest
withdraw
reduct
mean
arteri
pressur
agonist
k
agonist
suppress
antagonist
revers
effect
indic
interact
opiat
system
inconsist
chang
blood
pressur
administr
opiat
antagonist
well
specif
manipul
probabl
respons
naloxon
produc
hypertens
situat
effect
other
naloxon
naloxon
methobromid
rais
inject
iv
suggest
action
occur
peripher
site
naloxon
methobromid
cross
bloodbrain
barrier
littl
closearteri
inject
either
hindquart
vasculatur
affect
blood
pressur
call
conclus
question
although
naloxon
alon
produc
small
rise
mean
arteri
pressur
naloxoneprecipit
withdraw
morphin
induc
larg
one
cardiovascular
system
highli
sensit
opiat
manipul
result
norbinaltorphimin
increas
blood
pressur
given
unanesthet
piglet
inject
hippocamp
format
rat
dose
use
treatment
ofautist
naltrexon
effect
blood
pressur
indic
cardiovascular
side
effect
worri
similar
result
report
opiat
modul
heart
rate
although
chang
blood
pressur
alway
correl
heart
rate
opposit
effect
found
metenkephalin
depend
cardiovascular
state
peptid
increas
heart
rate
normal
condit
reduc
anim
experienc
induc
hypotens
morphin
produc
bradycardia
case
damgo
direct
respons
vari
morphin
depend
dose
tachycardia
occur
dose
increas
heart
rate
also
seen
hydromorphon
dermorphin
affect
action
except
fourth
day
chronic
administr
speed
remifentanil
alfentanil
decreas
puls
rate
variou
k
agonist
differenti
effect
heart
rate
well
reduc
given
iv
hippocamp
format
effect
icv
administr
bradycardia
occur
icv
inject
dynorphin
normal
condit
latter
alter
heart
rate
given
central
hemorrhageinduc
hypotens
hemorrhag
dynorphin
also
inact
hemorrhag
increas
heart
rate
dynorphin
dynorphin
b
howev
affect
dynorphin
may
play
complex
role
regul
cardiovascular
tempor
homeostasi
k
agonist
pd
slow
heart
rate
ici
effect
logic
gener
could
drawn
concern
action
k
agonist
respons
similar
find
occur
agonist
microinject
dadl
supraopt
nucleu
paraventricular
nucleu
effect
heart
rate
dpdpe
reduc
effect
dpdpe
alter
vagotomi
lesion
attenu
bradycardia
produc
morphin
damgo
suggest
vagu
nerv
play
role
effect
u
agonist
mix
agonist
antagonist
pentazocin
increas
heart
rate
effect
partial
revers
naltrexon
effect
probabl
opiat
natur
naloxon
effect
heart
rate
morphinedepend
rat
precipit
withdraw
produc
biphas
respons
heart
rate
first
reduc
speed
naltrexon
alon
effect
heart
rate
microinject
hippocampu
rat
block
bradycardia
antagonist
produc
tachycardia
piglet
howev
perhap
due
speci
differ
opiat
system
may
mediat
rhythmic
well
pace
heart
beat
k
agonist
pd
induc
arrhythmia
isol
rat
heart
intact
rat
electr
stimul
vagu
produc
arrhythmia
reduc
complet
allevi
inject
metenkephalin
epinephrinestimul
arrhythmia
facilit
k
agonist
ethylketocyclazocin
inhibit
tt
agonist
morphin
morphiceptin
indic
kind
receptor
involv
anoth
cardiovascular
respons
appear
opiat
mediat
blood
flow
morphin
reduc
neurohypophys
blood
flow
dose
affect
blood
pressur
two
measur
complet
correl
remifentanil
alfentanil
also
decreas
blood
flow
cortex
hippocampu
caudat
occur
dose
also
reduc
blood
pressur
heart
rate
naloxon
howev
alter
cerebr
blood
flow
patient
complex
partial
seizur
measur
pet
role
endogen
opiat
system
clear
naloxon
increas
blood
flow
stomach
small
intestin
colon
spleen
well
renal
coronari
blood
flow
endotoxin
shock
may
opiat
system
might
mediat
blood
flow
stress
effect
attenu
blocker
propranolol
thu
indic
interact
opiat
action
howev
renal
blood
flow
affect
dermorphin
suggest
u
receptor
involv
respons
hypotens
induc
acut
hemorrhag
opiat
system
might
play
role
concentr
preproenkephalin
cn
chang
dynorphin
administ
icv
hemorrhag
exacerb
decreas
blood
pressur
slow
recoveri
cardiovascular
function
dynorphin
attenu
recoveri
stroke
volum
affect
heart
rate
cardiac
output
given
hemorrhag
nucleu
ambiguu
dynorphin
produc
transient
suppress
blood
pressur
alter
hemorrhag
inject
dynorphin
nucleu
solitari
tract
effect
cardiovascular
measur
except
increas
heart
rate
dynorphin
appear
form
dynorphin
involv
respons
hemorrhag
differenti
effect
fragment
test
leav
unclear
pictur
naloxon
produc
pressor
effect
hemorrhag
reduc
tissu
damag
result
reperfus
hemorrhag
suggest
endogen
opiat
system
might
play
deleteri
role
effect
acut
bleed
chang
opiat
system
report
correl
cardiovascular
activ
diurnal
increas
plasma
immunoreact
peak
time
highest
heart
rate
occur
hors
suggest
peptid
might
mediat
respons
howev
chang
plasma
dynorphin
hypertens
patient
given
clonidin
even
though
heart
rate
blood
pressur
declin
patient
undergo
hemodialysi
increas
plasma
first
stage
isol
ultrafiltr
subsequ
decreas
second
stage
isovolem
bicarbon
hemodialysi
suggest
rise
analog
anim
hypovolem
shock
drop
might
due
neg
feedback
effect
endorphin
releas
hemorrhag
rat
increas
preproenkephalin
midbrain
spinal
cord
brain
stem
decreas
provid
addit
evid
opiat
system
might
involv
cardiovascular
activ
bind
dpdpe
amygdala
greater
spontan
hypertens
rat
normal
area
hippocampu
hypothalamu
corpu
striatum
midbrain
cortex
pon
medulla
spinal
cord
differ
clear
bind
amygdala
relat
increas
blood
pressur
genet
dispos
rat
howev
number
site
affin
greater
much
interest
possibl
role
opiat
system
modul
respir
thermoregul
recent
year
true
well
wellknown
clinic
find
opiat
agonist
depress
respir
confirm
find
morphin
damgo
ligand
includ
dermorphin
hydromorphon
sufentanil
metenkephalin
r
agonist
ici
suppress
ventilatori
function
although
ici
high
dose
addit
alter
respir
administ
alon
revers
depress
damgo
morphin
assum
k
receptor
primari
effect
respons
receptor
microinject
agonist
either
supraopt
nucleu
paraventricular
nucleu
fail
alter
ventil
either
site
receptor
involv
regul
respir
opiat
agonist
depress
ventilatori
respons
morphin
produc
longlast
suppress
chang
age
children
even
given
rout
previous
report
effect
opiat
system
appear
interact
agent
action
respir
depress
dermorphin
antagon
naloxon
also
benzodiazepin
antagonist
flumazenil
effect
benzodiazepin
agonist
alprazolam
depend
dose
small
dose
potenti
suppress
dermorphin
larger
dose
revers
benzodiazepinegaba
receptor
complex
therefor
modul
respiratori
depress
u
agonist
pretreat
nimodipin
ca
antagonist
potenti
effect
ofsufentanil
metenkephalin
inhibit
serotonininduc
respiratori
rhythm
mollusc
lymnaea
stagnali
indic
opiat
interact
action
ventil
gener
opiat
antagonist
produc
opposit
result
agonist
especi
antagonist
naloxon
naltrexon
facilit
respir
varieti
situat
antagonist
receptor
type
affect
respir
antagonist
naltrindol
k
antagonist
norbinaltorphimin
respiratori
frequenc
piglet
naloxon
increas
ventilatori
respons
hypox
progress
hypercapnia
normal
individu
ineffect
diabet
without
accompani
autonom
neuropathi
appear
therefor
ventilatori
respons
impair
diabet
naltrexon
reduc
hypox
event
improv
blood
ga
pattern
patient
obstruct
sleep
apnea
syndrom
effect
correl
sleep
pattern
indic
role
endogen
opiat
system
disord
age
appear
crucial
factor
naloxon
consist
improv
ventilatori
respons
infant
produc
conflict
result
adult
sometim
stimul
time
affect
breath
similarli
anim
effect
naltrexon
decreas
age
naloxon
potenti
respons
acetylcholin
physostigmin
either
increas
activ
neuron
ventral
medullari
surfac
antagonist
also
increas
respons
h
ion
superfus
suggest
opiat
system
might
involv
central
regul
respir
interact
cholinerg
structur
area
brain
activ
ca
channel
may
elicit
releas
endogen
opiat
peptid
medullari
respirationrel
structur
naloxon
revers
ventilatori
depress
produc
ca
agonist
bay
enantiom
bay
naloxoneprecipit
withdraw
acut
morphin
antagonist
reduc
inspiratori
phase
thu
demonstr
facilit
respir
opposit
typic
find
report
fetal
lamb
morphin
agonist
deltorphin
stimul
fetal
breath
naloxonazin
highli
specif
u
antagonist
naltrindol
antagonist
alon
suppress
inhibit
increas
morphin
deltorphin
respect
high
dose
naloxonazin
also
block
effect
deltorphin
lose
receptor
specif
higher
dose
thu
endogen
opiat
system
appear
play
tonic
role
u
receptor
control
breath
least
fetu
increas
concentr
opiat
peptid
occur
respiratori
difficulti
provid
addit
evid
involv
opiat
system
ventil
activ
endogen
opiat
report
intens
inspiratori
flowresist
load
opiat
mediat
vari
degre
acidosi
measur
lactic
acid
specif
resist
load
increas
plasma
normal
diabet
although
hypoxia
rais
csf
children
apnea
victim
sudden
infant
death
syndrom
higher
normal
baselin
concentr
suggest
increas
etiolog
signific
disord
secondari
hypoxia
distress
mechan
ventil
neonat
first
day
life
plasma
higher
normal
drop
start
morphin
suggest
infant
given
adequ
analgesia
without
concern
respiratori
effect
one
conflict
report
howev
found
increas
plasma
decreas
apnea
infant
apnea
ofprematur
given
xanthin
indic
neg
correl
peptid
respiratori
difficulti
chang
occur
infant
respond
xanthin
treatment
thu
continu
apnea
explan
discrep
given
regul
bodi
temperatur
opiat
system
also
studi
much
work
indic
opiat
agonist
reduc
temperatur
u
k
receptor
seem
involv
morphin
lower
dadl
howev
effect
lead
reject
idea
involv
receptor
respons
morphin
report
biphas
effect
first
decreas
increas
temperatur
may
account
conflict
fnding
hyperthermia
morphin
measur
might
occur
second
phase
although
bodi
temperatur
one
studi
block
hypothermia
induc
cerebr
ischemia
suggest
role
k
receptor
thermoregul
dynorphin
howev
effect
mice
subject
ischemia
sham
oper
differ
receptor
subtyp
might
involv
traumat
brain
injuri
interf
abil
morphin
increas
brain
temperatur
peptid
rais
uninjur
anim
numer
variabl
affect
thermoregulatori
effect
opiat
nmda
antagonist
given
daili
chronic
morphin
inhibit
develop
toler
analgesia
effect
opiat
hypertherm
effect
indic
dissoci
action
hypothermia
analgesia
howev
block
suggest
interact
k
nmda
receptor
nitric
oxid
also
influenc
opiat
mediat
temperatur
nitric
oxid
synthas
inhibitor
monomethyllarginin
attenu
develop
toler
hypothermia
rat
mice
decreas
temperatur
also
block
thyrotropinreleas
hormon
hormon
affect
bind
morphin
probabl
interact
receptor
physiolog
chang
pregnanc
potenti
morphineinduc
hypothermia
greatest
drop
seen
day
parturit
pregnanc
anim
slower
recov
hypothermia
day
parturit
recoveri
occur
faster
control
provid
addit
evid
opiat
interact
system
saccharin
enhanc
hypotherm
effect
morphin
attenu
hypertherm
phase
support
view
sweet
substanc
influenc
endogen
opiat
system
opiat
antagonist
small
effect
best
bodi
temperatur
naltrexon
effect
thermoregul
autist
children
rat
pup
chronic
naltrexon
enhanc
hypertherm
respons
morphin
probabl
due
upregul
receptor
brain
region
spinal
cord
drop
temperatur
administr
calcium
block
norbinaltorphimin
naloxon
naltrindol
decreas
calcitonin
generel
peptid
inhibit
three
antagonist
suggest
interact
opiat
system
substanc
increas
bind
frontal
cortex
ethanolinduc
hypothermia
mice
select
bred
high
low
sensit
heat
chang
u
pathway
may
involv
mediat
differenti
hypotherm
respons
strain
men
submers
cold
water
howev
relationship
core
temperatur
plasma
indic
opiat
system
probabl
play
role
temperatur
chang
situat
previou
demonstr
involv
endogen
opiat
seizur
activ
confirm
agonist
tend
proconvuls
k
agonist
anticonvuls
action
u
agonist
includ
morphin
metabolit
cdiprenorphin
produc
seizur
activ
administ
agonist
metenkephalin
absenc
seizur
precipit
hyperventil
cdiprenorphin
seen
patient
primari
gener
epilepsi
use
pet
procedur
patient
undergo
surgeri
within
min
inject
morphin
epileptiform
brain
wave
activ
similar
benign
epilepsi
seen
increas
serum
concentr
opiat
number
spike
discharg
initi
increas
decreas
relev
patient
welfar
clear
rat
low
dose
inject
icv
produc
seizur
attenu
nmda
antagonist
cpp
clear
reflect
interact
opiat
system
nmda
receptor
howev
naloxon
affect
seizur
indic
might
opiat
action
brief
nonleth
convuls
produc
mice
u
antagonist
naltrexon
antagonist
naltrindol
reduc
indic
opiat
control
singl
inject
diminish
capac
produc
second
seizur
even
week
later
suggest
possibl
toler
effect
administr
metenkephalin
amygdala
produc
kindl
rat
character
part
wetdog
shake
electr
kindl
amygdala
produc
similar
respons
combin
two
although
enkephalin
involv
wetdog
shake
drop
sooner
absent
howev
proteas
inhibitor
prevent
degrad
metenkephalin
reduc
incid
intens
seizur
seizuresuscept
mice
indic
anticonvuls
effect
find
cerebr
concentr
enkephalin
increas
proteas
inhibitor
suggest
rise
enkephalin
respons
decreas
seizur
action
might
differ
particular
strain
oppos
other
account
converg
result
seizur
induc
picrotoxin
potenti
morphin
effect
block
naloxon
suggest
opiat
receptor
involv
naloxon
alon
reduc
durat
postseizur
immobl
picrotoxin
effect
develop
toler
proconvuls
agent
endogen
antiopi
inhibit
morphineinduc
lengthen
durat
postseizur
akinesia
potenti
morphin
increas
number
focal
seizur
episod
indic
opiat
action
may
depend
type
seizur
convers
seizur
activ
alter
potenc
morphin
analgesia
facilit
suggest
chang
opiat
mechan
experi
convuls
support
anticonvuls
action
receptor
came
find
analogu
inhibit
seizur
maxim
electroshock
seizur
test
electr
stimul
hippocampu
although
high
dose
increas
pentylenetetrazolinduc
seizur
type
seizur
therefor
import
k
agonist
morphin
dynorphin
dynorphin
inhibit
epileptiform
activ
produc
continu
perfus
penicillin
bicucullin
hippocamp
slice
guinea
pig
clear
whether
action
opiat
block
naloxon
naloxon
alon
similar
antiepilept
effect
pentylenetetrazolinduc
seizur
respond
k
agonist
manipul
alter
direct
effect
depend
phase
circadian
rhythm
peptid
proconvuls
action
day
anticonvuls
action
night
possibl
due
interact
dopamin
plasma
elev
patient
statu
epilepticu
differ
concentr
good
prognosi
bad
one
find
alway
correl
ofcsf
csf
level
decreas
interict
postict
time
complex
partial
seizur
gener
tonicclon
seizur
concentr
metenkephalin
affect
seizur
except
gener
tonicclon
one
doubl
normal
valu
hippocampu
concentr
metenkephalin
dynorphin
decreas
seizur
whether
produc
kainic
acid
electroconvuls
shock
nmda
agonist
glutam
declin
rebound
normal
level
amount
rebound
depend
kind
kindl
also
increas
preproenkephalin
mrna
hippocampu
glutamateinduc
seizur
well
produc
escal
dose
cocain
latter
rais
preprodynorphin
mrna
indic
involv
opiat
system
epilept
activ
addit
support
idea
came
report
increas
g
bind
amygdala
kindl
cdiprenorphineinduc
seizur
enhanc
bind
occur
primarili
portion
cortex
amygdala
caudat
putamen
central
gray
thalamu
substantia
nigra
nearli
month
later
howev
lower
normal
bind
occur
area
seizur
induc
cdiprenorphin
bind
cortex
increas
overal
bind
remain
nonu
bind
primarili
k
decreas
might
help
explain
find
anticonvuls
properti
k
agonist
past
year
investig
role
opiat
system
brain
injuri
clearcut
pattern
emerg
although
appear
opiat
affect
recoveri
agonist
antagonist
reduc
deficit
morphin
injuri
provid
protect
naloxon
given
injuri
past
typic
find
indic
k
agonist
especi
dynorphin
act
opposit
way
potenti
deficit
support
idea
came
report
k
antagonist
nalmefen
facilit
recoveri
howev
given
twice
spinal
cord
injuri
also
improv
recoveri
decreas
vascular
permeabl
edema
function
k
receptor
traumat
cn
injuri
understood
time
perhap
time
administr
crucial
find
previou
year
deleteri
effect
dynorphin
motor
function
confirm
report
inject
dynorphin
produc
revers
hindlimb
paralysi
rat
anim
model
tardiv
dyskinesia
give
chronic
fluphenazin
affect
damgo
dpdpe
suggest
none
three
major
opiat
receptor
type
mediat
naloxon
potent
suppress
opiat
system
might
play
role
discrep
may
due
rout
administr
drug
agonist
given
icv
antagonist
sc
indic
possibl
peripher
mediat
disord
although
chang
metenkephalin
striatum
effer
system
patient
parkinson
diseas
although
synthet
dynorphin
spiradolin
effect
motor
perform
patient
pet
studi
reveal
decreas
bind
analogu
naltrexon
bind
u
k
receptor
primat
model
parkinson
diseas
may
alter
opiat
system
diseas
whether
chang
caus
result
diseas
remain
determin
role
cerebr
ischemia
also
studi
equal
confus
find
k
agonist
enadolin
afford
neuroprotect
given
ischemia
reduc
volum
infarct
brain
swell
pretreat
either
dynorphin
prevent
impair
memori
due
cerebr
ischemia
measur
spontan
recoveri
transfer
stepthrough
latenc
k
antagonist
nalmefen
howev
also
protect
ischem
event
reduc
glutam
releas
although
bind
naloxon
diprenorphin
hippocampu
increas
due
forebrain
ischemia
gerbil
neither
damag
pyramid
cell
chang
bind
affect
pretreat
subsequ
inject
agonist
antagonist
test
includ
morphin
diprenorphin
dextromethorphan
naloxon
naltrexon
lead
question
concern
part
opiat
play
ischemia
might
involv
opiat
system
alzheim
diseas
chang
opiat
bind
brain
seen
patient
disord
amount
influenc
natur
role
diseas
howev
remain
determin
loss
bind
site
hippocampu
putamen
alzheim
patient
well
decreas
k
receptor
putamen
although
k
bind
increas
amygdala
patient
bind
agonist
unchang
metor
leuenkephalin
decreas
almost
brain
area
studi
alter
csf
endorphin
immunoreact
occur
alzheim
diseas
increas
dynorphin
prodynorphin
mrna
hippocampu
age
greatest
chang
seen
greatest
learn
deficit
interest
possibl
mediat
headach
endogen
opiat
patient
cluster
headach
either
cluster
period
remiss
decreas
peripher
blood
persist
abnorm
level
even
painfre
period
suggest
primari
alter
regul
peptid
patient
disord
tension
headach
appear
involv
upregul
opiat
system
second
exterocept
suppress
period
tempor
muscl
chronic
attenu
abolish
headach
patient
inhibit
partial
block
naloxon
opiat
receptor
circuitri
hyperact
tension
headach
respons
immun
cell
metenkephalin
differ
group
normal
suffer
migrain
headach
either
attack
small
differ
within
individu
attack
painfre
period
suggest
peptid
may
indirect
role
pathogenesi
migrain
opiat
agonist
exert
much
control
neural
activ
interest
determin
natur
regul
remain
high
among
concern
specif
action
particular
agonist
brain
activ
measur
cortic
electroencephalograph
eeg
techniqu
chang
potenti
neuron
pathway
also
receiv
attent
role
opiat
system
sleep
gener
opiat
peptid
inhibit
neuron
excit
mani
produc
hyperpolar
cell
membran
although
except
occur
peptid
produc
facilit
mani
case
morphin
biphas
effect
eeg
measur
first
produc
highwav
slowwav
burst
associ
behavior
stupor
induc
eeg
behavior
excit
produc
slowwav
sleep
latenc
slowwav
sleep
increas
stupor
stage
increas
spectral
power
hz
rang
morphin
agonist
dpdpe
inhibit
excitatori
phase
antagonist
dalc
attenu
chang
spectral
power
morphin
effect
dpdpe
morphineinduc
chang
suggest
modul
morphin
receptor
alter
spectral
power
strain
depend
greater
lewi
rat
fischer
rat
indic
import
genet
variabl
effect
fetal
lamb
morphin
increas
leg
activ
action
revers
naloxonazin
ul
receptor
appar
mediat
human
dose
morphin
impair
cognit
abil
involv
process
serial
present
inform
chang
leg
pattern
behavior
electr
measur
correl
chronic
morphin
rat
reduc
total
spectral
power
rat
selfadminist
decreas
activ
yoke
rat
receiv
amount
morphin
group
also
disrupt
diurnal
ultradiurn
rhythm
leg
total
power
morphin
increas
spontan
fire
major
neuron
nucleu
accumben
rat
shorten
durat
accumbensevok
shortlat
excit
attenu
magnitud
longlat
inhibit
also
inhibit
respons
ventral
pallidum
project
neuron
respons
revers
naloxon
gaba
agonist
bicucullin
suggest
opiat
gaba
interact
ventralstriatopallid
pathway
inconsist
find
effect
morphin
neuron
report
agonist
produc
decreas
normal
activ
case
higher
spontan
fire
rate
greater
morphineinduc
increas
amp
anoth
morphinedepend
anim
morphin
effect
potenti
opiat
respons
forskolin
attenu
action
morphin
structur
therefor
interact
camp
remain
determin
morphin
inhibit
spontan
electr
activ
oxytocinsecret
neuron
rat
supraopt
nucleu
reduc
plasma
oxytocin
effect
inhibit
administr
pertussi
toxin
stimul
anterior
ventral
area
third
ventricl
opiat
mediat
oxytocin
neuron
may
complex
modul
phrenic
nerv
discharg
amplitud
also
occur
morphin
decreas
revers
naloxon
suggest
splanchnic
sympathet
regul
opiat
damgo
like
morphin
variabl
result
increas
primari
popul
spike
amplitud
ca
pyramid
cell
rat
hippocampu
naltrexonebut
naltrindolerevers
way
suggest
mediat
record
dentat
granul
cell
rat
hippocampu
howev
demonstr
hyperpolar
peptid
reduc
synapt
potenti
mediat
gaba
gabaa
gabab
receptor
similarli
damgo
inhibit
neuron
nucleu
tractu
solitariu
rat
reduc
gabamedi
evok
potenti
effect
attenu
naloxon
indic
tt
action
likewis
agonist
hyperpolar
nonburst
lt
low
threshold
ca
spike
nonlt
cell
guinea
pig
paraventricular
nucleu
dorsal
root
ganglion
cell
bodi
ca
current
vari
dramat
damgo
variabl
possibl
relat
differ
sensori
modal
among
ganglion
neuron
possibl
artifact
k
agonist
primarili
inhibitori
effect
electr
respons
produc
occasion
highvoltag
eeg
slowwav
burst
associ
increas
spectral
power
hz
band
also
suppress
spontan
activ
supraopt
oxytocin
neuron
activ
evok
stimul
area
around
third
ventricl
morphin
unlik
morphin
attenu
spontan
activ
revers
pertussi
toxin
activ
oxytocin
neuron
stimul
k
agonist
toler
morphin
affect
action
situat
nicotin
transmiss
superior
cervic
ganglia
depress
r
peptid
howev
u
antagonist
k
antagonist
inhibit
effect
k
receptor
might
mediat
respons
presynapt
calyciform
nerv
termin
chick
ciliari
ganglia
produc
hyperpolar
appar
increas
input
resist
inhibit
spontan
occur
miniatur
hyperpolar
termin
consid
due
k
conduct
effect
abolish
k
antagonist
norbinaltorphimin
action
site
probabl
mediat
k
receptor
dynorphin
nucleu
tractu
solitariu
rat
hyperpolar
neuron
test
associ
activ
k
conduct
although
agonist
effect
stimul
dynorphincontain
dentat
granul
cell
guinea
pig
hippocampu
releas
dynorphin
activ
k
receptor
activ
reduc
excitatori
transmiss
addit
releas
dynorphin
block
induct
longterm
potenti
granul
cellperfor
path
synaps
suggest
endogen
dynorphin
function
retrograd
inhibitori
transmitt
role
k
receptor
clearli
remain
determin
role
receptor
equal
confus
indic
studi
dpdpe
peptid
increas
eeg
activ
fetal
lamb
effect
alter
antagonist
naltrindol
revers
antagonist
naloxonazin
rat
dpdpe
increas
total
spectral
power
highvoltag
burst
also
suppress
eeg
behavior
excit
morphin
attenu
antagonist
dpdpe
agonist
differenti
effect
differ
pathway
increas
spike
amplitud
ca
pyramid
cell
predomin
receptor
subtyp
effect
antagon
naltrindol
support
involv
tl
receptor
increas
concentr
dopac
dopa
nucleu
accumben
median
emin
administr
dpdpe
blockag
naltrindol
demonstr
activ
dopaminerg
neuron
probabl
mediat
receptor
dentat
granul
cell
superior
cervic
ganglia
howev
dpdpe
produc
hyperpolar
effect
neuron
nucleu
tractu
solitariu
administr
dadl
epicardi
ganglia
increas
spontan
neural
activ
system
inject
produc
effect
effect
site
specif
peptid
also
increas
primari
secondari
popul
spike
potenti
pyramid
cell
action
revers
naltrexon
highli
specif
receptor
role
receptor
situat
must
question
support
view
came
find
agonist
dslet
also
rais
spike
amplitud
action
revers
either
naltrindol
anoth
antagonist
inhibit
naltrexon
deltorphin
reduc
frequenc
hippocamp
electr
activ
rhythmic
electr
pattern
stress
rabbit
indic
inhibitori
effect
peptid
situat
dala
analogu
howev
effect
activ
either
nucleu
tractu
solitariu
pyramid
cell
suggest
receptor
play
role
electr
activ
area
thu
indirectli
support
idea
receptor
import
leuenkephalin
increas
electr
activ
pyramid
cell
dala
leuenkephalin
produc
slow
depolar
associ
signific
conduct
increas
metacerebr
giant
cell
marin
mollusc
aplysia
californica
appear
act
stimul
adenyl
cyclas
product
camp
inject
arteri
suppli
superior
cervic
ganglia
leuenkephalin
reduc
postganglion
compound
action
potenti
evok
test
shock
cervic
sympathet
trunk
cat
indic
enkephalin
inhibitori
effect
action
antagon
naloxon
receptor
involv
clear
peptid
action
metenkephalin
depend
specif
condit
studi
enkephalin
increas
input
conduct
locu
coeruleu
effect
almost
total
abolish
combin
sodium
substitut
extracellular
ba
conclud
opiat
respons
area
open
k
channel
suppress
rest
nadepend
inward
conduct
metenkephalin
also
facilit
nonrectifi
electr
coupl
respiratori
neuron
helix
pomantia
coupl
serotonincontain
ciliomotoneuron
lymnaea
stagnali
enkephalin
may
involv
coordin
motor
pattern
isol
cn
neuron
peptid
produc
weak
hyperpolar
depolar
lymnaea
stagnali
inhibit
serotonininduc
respiratori
rhythm
temporarili
later
slow
oscil
membran
potenti
dentat
granul
cell
metenkephalin
produc
hyperpolar
cell
effect
potenti
enkephalinas
inhibitor
thiorphan
animopeptidas
inhibitor
bestatin
attenu
antagonist
ctop
agoni
also
reduc
synapt
potenti
mediat
gaba
thu
indic
interact
opiat
gaba
system
respons
agonist
morphiceptin
inhibit
nicotin
transmiss
superior
cervic
ganglion
cat
effect
revers
ici
antagonist
naloxon
ctap
suggest
u
mediat
respons
stimulu
train
axon
also
depress
activ
inhibit
block
naloxon
action
also
probabl
modifi
receptor
locu
coeruleu
buprenorphin
reduc
normal
electr
activ
repeat
present
opiat
produc
toler
alfentalil
howev
affect
eeg
measur
even
dose
impair
cognit
abil
k
agonist
reduc
renal
sympathet
nerv
activ
effect
neuron
nucleu
tractu
solitariu
heroin
increas
activ
dopamin
cell
decreas
activ
nondopamin
cell
ventral
tegment
area
indic
dopamin
opiat
interact
support
rat
selfadminist
heroin
dopaminerel
electrochem
signal
increas
first
inject
day
subsequ
inject
produc
biphas
effect
first
suppress
stimul
neural
activ
rat
yoke
determin
administr
similar
weaker
effect
specif
action
opiat
excitatori
inhibitori
postsynapt
potenti
epsp
ipsp
differ
area
brain
primarili
inhibitori
natur
dentat
granul
cell
hippocampu
dynorphin
reduc
excitatori
transmiss
shown
decreas
epsp
evok
stimul
perfor
path
dslet
damgo
suppress
orthodrom
stimul
ipsp
ca
pyramid
cell
hippocampu
metenkephalin
damgo
decreas
frequenc
chang
amplitud
distribut
gabaerg
spontan
miniatur
ipsp
hyperpolar
neuron
membran
produc
reduc
extracellular
k
ca
concentr
effect
ipsp
action
enkephalin
indic
opiat
peptid
direct
action
presynapt
gabaerg
termin
similarli
u
agonist
reduc
ipsp
epsp
hippocamp
cell
independ
ofk
ca
conduct
probabl
due
gproteinmedi
inhibit
vesicular
gaba
releas
process
glutamatemedi
epsp
nucleu
tractu
solitariu
attenu
damgo
dynorphin
dpdpe
dalaz
deltorphin
agonist
stronger
effect
agonist
nucleu
accumben
naloxon
block
ethanolproduc
reduct
amplitud
epsp
evok
stimul
peritubercl
region
ventral
nucleu
accumben
suggest
ethanol
might
act
opiat
mechan
tracer
inject
arcuat
nucleu
use
measur
enkephalin
immunoreact
structur
determin
arcuat
nucleu
target
enkephalinerg
control
origin
sever
region
act
neuron
project
synaps
dorsal
ventral
parabrachi
neuron
medial
preoptic
area
hypothalam
paraventricular
nucleu
administr
opiat
antagonist
well
agonist
electr
activ
naloxon
suppress
inhibit
activ
superior
cervic
ganglia
induc
short
stimulu
train
chronic
morphin
inject
naloxon
precipit
withdraw
character
hyperact
locu
coeruleu
agent
increas
serotonerg
neurotransmiss
attenu
effect
antagonist
indic
interact
opiat
serotonin
system
naloxonazin
reduc
eeg
activ
fetal
lamb
naltrindol
action
rat
thu
antagonist
like
agonist
specif
action
appear
rule
sleep
pattern
measur
eeg
activ
influenc
opiat
morphin
increas
latenc
slowwav
sleep
naltrexon
reduc
total
sleep
time
amount
slowwav
sleep
amount
rem
rapid
eye
movement
sleep
increas
total
awak
time
number
awaken
sleep
patient
obstruct
sleep
apnea
suggest
endogen
opiat
system
overact
young
piglet
naltrexon
effect
sleepwak
cycl
naltrindol
decreas
percentag
time
spent
sleep
increas
wake
older
pig
antagonist
produc
awak
time
k
antagonist
affect
sleepwak
state
either
age
find
indic
earli
neonat
period
receptor
modul
rhythm
sleep
wake
later
behavior
modifi
receptor
well
k
receptor
probabl
play
role
interest
possibl
modul
gener
activ
locomot
opiat
system
remain
high
although
new
insight
discov
effect
opiat
agonist
depend
greatli
dose
experiment
variabl
gener
could
made
mani
agonist
show
biphas
effect
time
typic
opiat
antagonist
tend
effect
suggest
littl
tonic
regul
activ
opiat
system
reduc
activ
also
continu
interest
propos
involv
endogen
opiat
respons
strenuou
exercis
report
action
morphin
highli
variabl
due
part
biphas
effect
locomot
produc
temporari
decreas
increas
closer
analysi
reveal
three
phase
motor
reactiv
morphin
initi
decreas
due
akinesia
follow
intermedi
period
character
akinesia
interrupt
sudden
burst
hyperact
third
stage
primarili
high
level
activ
site
action
opiat
also
import
morphin
effect
inject
anterior
dorsal
posterior
dorsal
striatum
stimul
locomot
administ
ventral
tegment
area
dorsal
periaqueduct
gray
ventromedi
ventrolater
striatum
conflict
report
effect
nucleu
accumben
compar
dose
produc
either
effect
greater
activ
rat
dose
cours
crucial
studi
focus
dose
morphin
produc
hyperact
studi
report
morphineinduc
hypoact
still
other
found
opiat
effect
motor
function
dose
stimul
activ
nap
oxon
block
effect
lower
one
higher
dose
produc
nonrevers
fear
hyperact
strain
differ
reactiv
morphin
found
mice
select
bred
high
swimstress
analgesia
less
sensit
low
swimstress
analgesia
presum
due
differenti
endogen
opiat
activ
strain
although
upregul
opiat
system
alon
due
previou
exposur
stress
affect
morphin
hyperact
pair
agonist
stress
potenti
reaction
suggest
state
opiat
system
influenc
action
exogen
opiat
opiat
dopamin
system
may
interact
mediat
locomotor
effect
morphin
correl
increas
activ
increas
dopamin
brain
similarli
treatment
pertussi
toxin
select
k
agonist
spiradolin
reduc
dopamin
turnov
also
inhibit
hyperact
due
morphin
dopaminerg
action
morphin
modifi
inhibitor
nitric
oxid
synthas
nitric
oxid
could
play
role
endogen
corticosteron
also
import
effect
adrenalectomi
reduc
abil
morphin
stimul
activ
find
damgo
report
stimul
motor
respons
whether
peptid
administ
ventral
striatum
ventral
pallidum
nucleu
accumben
icv
system
biphas
reaction
initi
decreas
increas
also
seen
although
dose
produc
hyperact
although
case
damgo
affect
activ
antagon
increas
induc
methamphetamin
suggest
receptor
might
mediat
dopaminerel
behavior
support
idea
damgo
like
morphin
facilit
dopamin
metabol
locomot
pretreat
pertussi
toxin
inhibit
administr
mix
dd
antagonist
antagonist
antagonist
reduc
action
damgo
indic
di
receptor
might
mediat
convers
k
agonist
tend
inhibit
locomot
least
low
dose
although
effect
case
guinea
pig
effect
indirect
locomot
difficult
due
abnorm
motor
respons
postur
induc
peptid
naloxon
norbinaltorphimin
attenu
effect
sigma
agonist
exacerb
involv
k
receptor
clear
suppress
stimul
motor
activ
morphin
apomorphin
k
receptor
interact
dopamin
situat
seem
alter
develop
receptor
given
prenat
howev
anim
reduct
locomot
agonist
quinpirol
agonist
report
hyperact
induc
naltrexon
revers
effect
suggest
k
receptor
mediat
respons
dynorphin
conflict
result
produc
behavior
activ
case
suppress
other
fragment
ofdynorphin
includ
well
complet
peptid
potenti
dorsal
immobl
respons
rat
destyrdynorphin
effect
inhibit
respons
indic
might
opiat
mediat
dynorphin
four
analogu
produc
motor
dysfunct
character
wild
run
form
activ
analogu
less
potent
whole
peptid
produc
respons
howev
dynorphin
affect
hyperact
damgo
even
though
revers
effect
agonist
indic
locomotor
action
receptor
type
independ
agonist
deltorphin
enhanc
immobl
respons
dynorphin
one
type
receptor
may
involv
support
idea
came
find
metenkephalin
fragment
also
increas
durat
immobl
dpdpe
produc
monophas
potenti
locomot
oppos
biphas
effect
damgo
lack
action
k
agonist
dakli
indic
differ
profil
receptor
even
within
receptor
type
differ
damgo
biphas
effect
dalda
suppress
locomot
consist
alfentanil
affect
simpl
motor
function
inhibit
fine
motor
behavior
provid
evid
idea
dpen
stimul
locomotor
behavior
dplpe
alter
hyperact
methamphetamin
agonist
differ
effect
k
agonist
reduc
motor
stimul
produc
cocain
indic
opiat
mediat
respons
opiat
agonist
antagonist
variabl
action
gener
activ
either
alter
suppress
although
report
stimul
locomot
methyl
naloxonazin
bromid
fooddepriv
satiat
rat
addit
naloxon
norbinaltorphimin
attenu
reduct
locomot
induc
thu
indirectli
increas
behavior
naloxon
methobromid
howev
effect
suggest
central
mediat
effect
naloxon
alon
inhibit
activ
effect
dorsal
immobl
respons
behavior
might
mediat
differ
receptor
anoth
antagonist
inhibit
morphineinduc
hyperact
neither
alon
k
antagonist
norbinaltorphimin
alter
fetal
motor
activ
role
opiat
peptid
respons
question
receptor
appear
play
role
locomot
naltrindol
benzofuran
deriv
naltriben
block
morphineinduc
hyperact
naltrindol
also
reduc
gross
motor
stimul
amphetamin
cocain
antagonist
dalc
effect
antagonist
combin
dalc
reduc
behavior
induc
amphetamin
manner
similar
naltrindol
conclud
subtyp
receptor
might
role
amphetamin
behavior
activ
addit
horizont
activ
indic
locomot
vertic
behavior
measur
rear
modifi
opiat
morphin
reduc
rear
anim
agonist
encount
neither
metabolit
affect
normal
condit
damgo
increas
rear
inject
striatum
nucleu
accumben
administ
icv
produc
biphas
effect
first
inhibit
stimul
b
agonist
dpen
increas
k
agonist
dakli
well
receptor
might
involv
damgo
antagon
methamphetamineinduc
rear
effect
apomorphinestimul
rear
neither
dynorphin
dplpe
alter
suggest
u
mediat
former
although
naloxon
methyl
naloxonium
bromid
given
central
affect
rear
satiat
rat
high
dose
quaternari
antagonist
increas
fooddepriv
rat
role
u
receptor
confus
best
circl
anoth
behavior
may
mediat
opiat
inject
morphin
ventral
tegment
area
rat
produc
contravers
circl
even
dose
small
enough
develop
toler
sensit
similarli
three
novel
benzomorphan
deoxypentazocin
deoxynbenzylnormetazocin
nbenzylnormetazocin
induc
circl
behavior
microinject
nigra
striatum
action
howev
thought
opiat
mediat
compound
low
affin
opiat
receptor
naloxon
affect
suggest
receptor
involv
instead
circl
induc
methamphetamin
antagon
damgo
unaffect
dplpe
u
receptor
may
interact
dopaminerel
agent
agonist
apomorphineinduc
circl
howev
chang
damgo
dplpe
dynorphin
suggest
mediat
three
major
opiat
receptor
type
role
opiat
system
behavior
therefor
total
unclear
groom
also
shown
previous
modul
endogen
opiat
studi
mostli
neg
neither
high
dose
morphin
low
dose
metabolit
inject
either
icv
alter
groom
rat
groom
induc
methamphetamin
dplpe
ineffect
chang
damgo
attenu
reduct
revers
suggest
mediat
respons
tt
receptor
damgo
alon
howev
produc
groom
opiat
involv
weak
best
dyston
movement
genet
predispos
hamster
reduc
either
induc
affect
naloxon
naltrexon
suggest
involv
k
receptor
behavior
nondyston
hamster
effect
peptid
depress
locomot
convers
normal
rat
produc
ataxia
ptosi
hunch
back
sedat
block
agonist
rimaczol
suggest
interact
k
receptor
similarli
guinea
pig
abnorm
motor
respons
postur
sever
impair
movement
occur
inject
support
find
k
agonist
debilit
properti
addit
support
idea
came
find
dynorphin
analogu
tend
produc
motor
dysfunct
character
hindlimb
jerk
popcorn
jump
barrel
roll
barrelrol
behavior
also
occur
administr
although
unusu
shortliv
suggest
peptid
opiatelik
agonist
effect
possibl
mediat
receptor
jump
well
agit
bite
vocal
induc
morphin
metabolit
massiv
bite
behavior
also
produc
intranigr
infus
dadl
although
clear
receptor
involv
muscular
rigid
specif
gastrocnemiu
muscl
occur
administr
alfentanil
effect
attenu
ul
antagonist
naloxonazin
suggest
mediat
balanc
measur
rotorod
affect
morphin
tyrmifi
combin
two
rat
pup
first
week
life
even
though
analgesia
modifi
opiat
natur
respons
unclear
opiat
mediat
stereotypi
also
studi
agonist
three
receptor
type
damgo
dpdpe
dakli
produc
stereotypi
rat
although
somewhat
differ
behavior
profil
especi
term
time
damgo
biphas
action
two
mix
effect
k
agonist
attenu
stereotypi
induc
cocain
suggest
involv
k
receptor
stereotyp
facial
wipe
behavior
respons
tactil
probe
rat
pup
reduc
drink
milk
inject
agonist
effect
milk
agonist
block
k
antagonist
norbinaltorphimin
antagonist
affect
action
suggest
milk
modul
activ
dopamin
receptor
turn
promot
activ
k
receptor
agonist
morphin
damgo
also
attenu
facial
wipe
receptor
appear
involv
k
receptor
howev
probabl
play
role
stereotypi
induc
de
agonist
bromocriptin
effect
involv
opiat
system
respons
strenuou
exercis
studi
previou
year
success
result
run
exhaust
increment
grade
treadmil
exercis
increas
rise
greater
recoveri
slower
marathon
run
less
strenuou
exercis
alter
plasmaendorphin
signific
differ
diabet
nondiabet
patient
silent
myocardi
ischemia
nondiabet
patient
without
silent
myocardi
ischemia
suggest
assess
might
use
diagnost
tool
baselin
differ
plasma
marathon
runner
sedentari
individu
effect
peptid
best
temporari
exercis
also
induc
increas
hemorphin
opiat
deriv
enzym
degrad
hemoglobin
baselin
differ
train
runner
nonexercis
control
sex
perhap
due
neg
covari
weight
voluntari
exercis
run
wheel
rat
higher
concentr
ofdynorphinconvert
enzym
csf
nonrun
control
provid
addit
evid
exercis
affect
endogen
opiat
system
propos
sustain
benefici
effect
exercis
blood
pressur
might
due
activ
opiat
system
produc
sympathoinhibit
although
inhibit
may
mask
exercis
sympathoexcitatori
influenc
exercis
complet
physiolog
effect
sustain
activ
opiat
system
may
predomin
produc
hypotens
exerciseinduc
reaction
howev
includ
acceler
transit
time
increas
releas
growth
hormon
rise
plasma
vasopressin
probabl
opiat
mediat
naloxon
naltrexon
effect
interest
postul
involv
opiat
system
develop
prenat
old
age
remain
high
even
increas
littl
attent
possibl
opiat
modul
sexual
behavior
dwindl
previou
year
find
howev
endogen
peptid
may
control
testosteron
biosynthesi
interact
vasopressin
system
naloxon
increas
testosteron
product
leydig
cell
reduc
testicular
vasopressin
inject
testi
chang
opiat
system
note
pregnanc
assum
endogen
opiat
help
regul
fetal
develop
late
pregnanc
concentr
metenkephalin
increas
plasma
fetal
sheep
total
amount
metenkephalincontain
peptid
chang
possibl
reflect
chang
synthesi
andor
secret
enkephalin
peptid
within
sympathet
nerv
parturit
near
level
gene
express
enkephalin
precursor
chang
brain
pregnanc
pomc
mrna
arcuat
nucleu
decreas
parturit
preproenkephalin
mrna
ventromedi
nucleu
decreas
late
pregnanc
parturit
paraventricular
nucleu
rose
parturit
declin
end
pregnanc
concentr
metenkephalin
also
increas
lumbar
region
spinal
cord
late
gestat
rat
possibl
associ
discomfort
prepar
labor
occur
time
neural
lobe
pituitari
decreas
peptid
may
respons
late
pregnanc
remov
inhibit
oxytocin
releas
occur
earlier
gestat
opiat
mediat
oxytocin
support
find
increas
hormon
occur
parturit
enhanc
naloxon
releas
electr
stimul
potenti
final
week
pregnanc
morphin
effect
electr
stimul
oxytocin
releas
although
inject
delay
start
birth
affect
progress
parturit
begun
methadoneexpos
placenta
villu
detect
opiat
bind
site
vitro
releas
acetylcholin
trophoblast
tissu
placenta
modul
opiat
suggest
methadon
produc
desensit
downregul
opiat
receptor
placenta
neural
lobe
dynorphin
supraopt
nucleu
prodynorphin
mrna
chang
gestat
period
spinal
cord
howev
dynorphin
increas
late
pregnanc
parturi
anim
dynorphin
remain
elev
addit
rise
dynorphin
support
role
k
receptor
parturit
find
given
birth
second
pup
litter
delay
birth
remain
pup
preinject
antagonist
norbinaltorphimin
block
effect
action
occur
result
interact
oxytocin
indic
fact
inject
hormon
attenu
delay
induc
opiat
peptid
block
spontan
oxytocinstimul
contract
parturit
analgesia
pregnanc
birth
process
also
appear
involv
k
receptor
administr
progesteron
nonpregn
rat
produc
analgesia
block
chronic
naltrexon
human
matern
plasma
increas
third
trimest
pregnanc
concentr
correl
crh
labor
matern
fetal
correl
concentr
fetal
obstetr
difficulti
parturit
cow
mark
increas
parallel
increas
oxytocin
even
extent
releas
episod
manner
conjunct
uterin
abdomin
contract
suggest
interact
oxytocin
pig
howev
chang
occur
pregnanc
alter
may
account
differenti
demonstr
stressinduc
anxieti
pregnant
rat
end
pregnanc
peptid
increas
anxieti
measur
buri
behavior
decreas
parturit
lactat
affect
opiat
system
opiatemedi
behavior
pomc
mrna
arcuat
nucleu
preproenkephalin
mrna
paraventricular
nucleu
increas
lactat
sheep
opiat
gene
express
modifi
even
termin
pregnanc
lactat
rat
attenu
analgesia
morphin
demonstr
chang
opiat
system
period
hyperalgesia
day
howev
coincid
decreas
stressinduc
buri
behavior
event
may
relat
previous
report
decreas
day
opiat
agonist
antagonist
shown
alter
fetal
behavior
term
stimul
fetal
motor
activ
although
morphin
damgo
effect
neither
norbinaltorphimin
alon
alter
k
antagonist
block
hyperact
induc
indic
interact
opiat
dopamin
system
morphin
damgo
attenu
facial
wipe
respons
cutan
stimuli
reduct
wipe
damgo
revers
ctop
inhibit
norbinaltorphimin
indic
u
k
receptor
might
mediat
respons
neither
antagonist
alon
naloxon
alon
howev
effect
facial
wipe
appear
littl
involv
endogen
opiat
behavior
habitu
wipe
respons
repeat
present
stimulu
unaffect
ctop
norbinaltorphimin
naloxon
norbinaltorphimin
naloxon
facilit
dishabitu
suggest
possibl
opiat
modul
ot
simpl
learn
fetu
classic
condit
use
pair
milk
inhibit
facial
wipe
fetu
sucros
facilit
ctop
norbinaltorphimin
indic
mediat
appropri
control
reduct
wipe
present
sucros
due
associ
milk
sucros
rather
habitu
confound
event
use
opiat
effect
condit
late
gestat
period
administr
promot
stretch
respons
salin
suggest
function
matur
k
receptor
occur
day
birth
present
artifici
nippl
rat
fetu
produc
appetit
respons
mouth
lick
oral
grasp
nippl
avers
respons
avoid
nippl
damgo
increas
appetit
behavior
reduc
increas
avoid
nippl
k
receptor
thu
mediat
opposit
respons
stimulu
might
reflect
differenti
develop
infus
milk
nearterm
fetal
rat
reduc
dopamin
receptor
septal
striatal
hypothalam
region
respons
affect
morphin
damgo
interact
dopamin
opiat
system
yet
develop
region
stage
prenat
administr
opiat
alter
postnat
behavior
rat
given
chronic
gestat
reduc
locomot
agonist
quinpirol
agonist
prenat
experi
chang
sensit
receptor
chronic
prenat
also
lower
birth
weight
pup
effect
last
first
day
peptid
alter
weight
gain
food
intak
mother
litter
size
number
dead
pup
appear
agonist
work
directli
fetus
indirectli
mother
prenat
morphin
combin
catecholamin
synthesi
inhibitor
cmethylparatyrosin
appar
modifi
develop
norepinephrin
system
turnov
rate
norepinephrin
adulthood
greater
normal
preoptic
area
less
normal
hypothalamu
adult
dopamin
turnov
howev
affect
prenat
morphin
similarli
prenat
event
modifi
later
opiatemedi
behavior
receiv
prenat
exposur
lead
rat
pup
given
morphin
implant
naloxoneprecipit
withdraw
high
level
lead
result
attenu
withdraw
sign
includ
less
weight
loss
fewer
wetdog
shake
fewer
mouth
respons
howev
corticosteron
level
use
index
withdraw
increas
indic
disrupt
typic
opiat
function
rat
prenat
exposur
cocain
abil
morphin
damgo
reduc
ultrason
vocal
neonat
rat
pup
enhanc
sensit
morphin
analgesia
affect
consist
increas
naloxon
bind
forebrain
brain
stem
associ
analgesia
rat
also
direct
demonstr
alter
endogen
opiat
system
prenat
experi
chronic
administr
morphin
middl
gestat
period
produc
chang
bind
adult
bind
capac
damgo
increas
preoptic
area
decreas
hypothalamu
latter
possibl
account
chang
adult
male
sexual
behavior
prenat
morphin
shown
previou
year
area
affect
experi
continu
matern
administr
naltrexon
provid
blockad
endogen
opiat
system
morphin
restrict
cortic
cell
prolifer
matur
measur
birth
effect
exogen
opiat
sever
matern
stress
shown
induc
endogen
opiat
activ
alter
hypothalam
measur
postnat
day
although
time
durat
stress
import
immobil
gestat
day
increas
endorphin
restraint
last
day
effect
occur
although
easi
explan
differ
opiat
system
chang
pregnanc
also
continu
develop
birth
basal
concentr
increas
anterior
pituitari
neurointermedi
pituitari
rat
old
age
haloperidol
potenti
rise
peptid
month
howev
indic
chang
interact
dopamin
opiat
system
age
ontogeni
preoptic
area
similar
male
femal
diffus
medial
portion
birth
later
becom
dens
periventricular
parastriat
nuclei
receptor
soleu
extensor
digitorum
longu
diaphragm
muscl
rat
decreas
age
denser
dystroph
mice
normal
one
suggest
role
opiat
system
develop
genet
disord
concentr
rose
plasma
fell
pituitari
hypothalamu
medulla
oblongata
respons
administr
fentanyl
rat
pup
system
activ
least
age
sooner
agerel
concentr
leuenkephalin
preoptic
area
vari
sex
although
start
initi
densest
later
portion
sex
male
distribut
expand
medial
portion
ultim
condens
later
part
medial
portion
femal
continu
exhibit
diffus
medial
preoptic
immunoreact
peptid
seen
human
rang
age
year
agerel
decreas
leuand
metenkephalin
caduat
nucleu
pallidum
chang
putamen
substantia
nigra
bind
enkephalin
hippocampu
caudat
nucleu
chang
age
life
span
rat
concentr
enkephalin
increas
neurointermedi
anterior
lobe
pituitari
haloperidol
reduc
metenkephalin
anterior
lobe
younger
anim
older
one
age
affect
opiat
respons
dopamin
blockad
structur
earliest
detect
proenkephalin
rat
striatum
occur
day
although
metenkephalin
first
seen
day
age
discrep
perhap
due
development
delay
complet
enzymat
process
proenkephalin
precursor
like
relat
dopamin
innerv
administ
neonat
rat
increas
preproenkephalin
mrna
adult
brain
mostli
striatum
also
surround
area
indic
earli
deplet
dopamin
last
effect
endogen
opiat
system
adulthood
larg
decreas
enkephalin
mrna
enkephalin
neuron
rat
striatum
suggest
chang
opiat
system
age
although
except
receptor
tend
rel
stabl
month
throughout
life
guinea
pig
rat
brain
number
u
receptor
rat
hypothalamu
decreas
age
rat
k
receptor
increas
amygdala
thalamu
age
rat
k
receptor
evid
birth
earliest
appear
chang
affin
age
u
receptor
highli
vulner
perinat
lead
toxic
k
receptor
less
sensit
perhap
fulli
develop
birth
sexual
isol
rat
birth
alter
number
receptor
u
antagonist
depress
given
day
day
support
notion
matur
birth
naloxon
bind
site
decreas
age
arcuat
nucleu
ventromedi
nucleu
median
emin
ovariectom
rat
treat
estradiol
inhibit
site
young
one
median
emin
middleag
age
one
indic
shift
interact
opiat
system
sex
hormon
age
perinat
administr
opiat
agonist
antagonist
influenc
later
behavior
obstetr
medic
could
risk
factor
futur
addict
perhap
due
perinat
imprint
anesthet
labor
uneven
distribut
adult
drug
abus
born
hospit
differ
polici
independ
geograph
area
neonat
morphin
delay
eye
open
attenu
weight
gain
rat
pup
well
produc
hyperalgesia
endogen
opiat
modul
peptid
alon
effect
potenti
effect
morphin
produc
differ
effect
young
anim
typic
found
adult
naloxon
administ
neonat
adult
rat
hyperalgesia
appar
alter
develop
antinocicept
mechan
effect
opiat
agonist
antagonist
chang
age
demonstr
report
releas
endogen
acetylcholin
rat
striatal
slice
inhibit
dpdpe
earlier
age
attenu
damgo
receptor
becom
oper
respect
respons
differenti
develop
similarli
chang
modul
sleep
respir
receptor
one
mediat
sleep
u
regul
respir
earli
neonat
period
later
receptor
involv
behavior
although
tend
predomin
respir
k
receptor
affect
respons
modul
cardiovascular
activ
indic
differenti
control
behavior
neonat
period
human
howev
chang
abil
morphin
suppress
ventilatori
respons
age
month
year
swiminduc
analgesia
rat
day
age
day
full
adultlik
analgesia
day
correspond
transit
u
receptor
time
wean
import
transit
delay
day
delay
wean
day
warmwat
swiminduc
analgesia
measur
increas
vocal
afterdischarg
threshold
naloxon
revers
adult
indic
chang
age
senescenceacceler
mice
control
naloxon
facilit
learn
month
age
month
antagonist
help
control
origin
dose
much
larger
dose
requir
effect
senescenceacceler
mice
indic
chang
opiat
system
advanc
age
notion
support
report
dynorphin
prodynorphin
mrna
hippocampu
increas
age
rat
greatest
rise
occur
sever
spatial
learn
deficit
opiat
system
appear
partial
involv
parent
behavior
naloxon
administ
new
monkey
mother
reduc
protect
behavior
toward
infant
attenu
groom
offspr
adult
well
relationship
mother
infant
disturb
antagonist
howev
demonstr
matern
behavior
opiat
mediat
other
morphin
decreas
cling
infant
mother
naltrexon
increas
demonstr
import
opiat
system
regul
affili
primat
mother
infant
exposur
juvenil
rat
neonat
pup
typic
produc
full
parent
behavior
administr
morphin
inhibit
naloxon
revers
effect
agonist
rat
allow
develop
full
parent
behavior
inject
morphin
still
naloxonerevers
attenu
suggest
onset
mainten
juvenil
rat
regul
opiat
administr
naltrexon
birth
wean
attenu
growth
measur
brain
bodi
weight
one
strain
rat
anoth
prolong
earli
prenat
receptor
blockad
opiat
receptor
affect
growth
although
effect
strain
specif
development
chang
seen
naltrexoneprecipit
withdraw
morphinedepend
rat
produc
differ
symptom
differ
pup
found
adult
pup
withdraw
character
stretch
walk
wall
climb
head
movement
decreas
time
litterm
oppos
typic
adult
symptom
teeth
chatter
wetdog
shake
diarrhea
jump
ptosi
chang
activ
level
strong
interest
remain
interact
opiat
system
immun
system
confus
result
seemingli
conflict
find
allow
gener
natur
undoubtedli
highli
complex
may
specif
effect
rather
widerang
conclus
outcom
research
concern
case
morphin
tend
inhibit
immun
function
agonist
suppress
natur
killer
nk
activ
given
either
acut
chronic
reduct
nk
activ
suppress
naltrexon
naloxonazin
naltrindol
norbinaltorphimin
indic
mediat
respons
cand
antagonist
also
block
effect
suggest
interact
opiat
pathway
similarli
measur
immun
function
produc
differenti
effect
morphin
spleen
morphin
suppress
nk
activ
also
product
interferon
blood
morphin
reduc
mitogen
respons
lymph
morphin
affect
abil
oflymphocyt
prolifer
produc
cytokin
chronic
morphin
less
nk
activ
peripher
blood
mononuclear
cell
probabl
due
decreas
percentag
cell
direct
inhibit
nk
cell
daili
morphin
also
produc
increas
percentag
lymphocyt
decreas
total
reciproc
increas
lymphocyt
well
greater
product
polyclon
immunoglobulin
ig
polyclon
igm
peripher
blood
mononuclear
cell
thu
daili
morphin
affect
immunocompet
could
implic
regul
viral
pathogen
drug
abus
especi
aid
vivo
vitro
morphin
reduc
phagocyt
activ
administr
candida
albican
action
block
naltrexon
indic
morphin
capabl
interact
directli
opiat
receptor
macrophag
result
decreas
phagocyt
function
increas
activ
neutral
endopeptidas
peripher
blood
mononuclear
cell
activ
concanavalin
cocain
alter
morphin
enkephalin
respons
probabl
opiat
mediat
morphin
act
directli
stimul
opiat
receptor
immun
cell
therebi
modul
macrophag
product
cytokin
respons
variou
stimuli
indirectli
trigger
opiat
receptor
periaqueduct
gray
may
activ
hpa
axi
subsequ
glucocorticoidmedi
effect
immun
cell
action
total
clear
howev
much
less
mechan
find
enkephalin
less
confus
similar
stimul
cell
migrat
produc
metenkephalinamid
dama
human
invertebr
mvtilu
eduli
suggest
possibl
univers
inhibitori
mechan
human
immunodefici
viru
hiv
slow
enhanc
migrat
produc
loss
direct
speci
enkephalinlik
molecul
similar
dama
earthworm
coelom
fluid
stimul
leukocyt
behavior
naloxonerevers
way
indic
opiat
mediat
respons
dpdpe
immunostimulatori
activ
topa
opposit
effect
healthi
individu
patient
leprosi
tuberculosi
indic
wide
differ
effect
select
enkephalin
incub
mous
spleen
cell
leuenkephalin
suppress
migrat
although
naloxon
alon
also
reduc
locomot
cell
antagonist
revers
action
enkephalin
cell
vietnam
veteran
suffer
ptsd
patient
migrain
metenkephalin
vari
effect
nk
activ
differ
nk
activ
outsid
migrain
attack
control
measur
group
analyz
individu
control
enkephalin
alter
immun
function
increas
control
outsid
attack
effect
half
attack
chang
migrain
headach
peptid
mostli
suppress
immun
activ
cell
veteran
metenkephalin
produc
mix
result
chronic
drug
user
effect
chronic
alcohol
abus
increas
nk
activ
individu
healthi
ptsd
convers
immun
system
also
alter
activ
endogen
enkephalin
splenocyt
nk
cell
nk
cell
activ
capabl
hydrolyz
ntermin
tyr
metand
leuenkephalin
propos
nk
cell
may
regul
enkephalin
activ
enzymat
degrad
case
facilit
immun
function
includ
reduc
incid
enceph
paralyticdemyelin
diseas
induc
neurotrop
murin
coronaviru
anim
model
multipl
sclerosi
accompani
reduct
replic
viru
brain
endorphin
also
enhanc
prolifer
phytohemagglutinin
lymphocyt
patient
chronic
ulcer
diseas
ia
express
routin
b
cell
cultur
spleen
cell
therebi
like
improv
antigenproduc
capac
suppress
antibodi
product
pokewe
mitogen
suggest
might
stimul
dualist
role
howev
report
stimul
tcell
prolifer
trigger
nonopi
receptor
increas
block
interact
opiat
receptor
conclud
fragment
peptid
contain
ctermin
lack
opiatebind
ntermin
sequenc
increas
tcell
prolifer
inhibit
ntermin
enkephalin
sequenc
pretreat
infect
temperaturesensit
mutant
vesicular
stomat
viru
reduc
immun
function
naloxonerevers
way
indic
opiat
mediat
deleteri
effect
endorphin
although
respons
crh
blunt
anorex
correl
neuroendocrin
impair
immun
respons
phytohemagglutinin
indic
peptid
play
role
action
thu
vari
effect
depend
number
factor
includ
fragment
kind
immun
respons
specif
popul
opiat
antagonist
consist
action
agonist
naltrexon
antagonist
block
enhanc
immun
function
melatonin
indic
mediat
tt
receptor
antagonist
naltrindol
inhibit
lymphocyt
reaction
kidney
allegraft
increas
surviv
suggest
naltrindol
may
safe
use
immunosuppress
agent
organ
transplant
howev
patient
brain
tumor
administr
naltrexon
addit
radiotherapi
increas
tumor
regress
rate
surviv
radiotherapi
alon
indic
involv
opiat
system
tumor
naloxon
differenti
effect
modul
nk
activ
human
peripher
blood
lymphocyt
vitro
direct
chang
depend
degre
nk
activ
increas
low
concentr
decreas
high
concentr
antagonist
also
modul
nk
activ
stimul
exogen
interferona
endogen
polyi
cinduc
interferon
direct
chang
depend
baselin
nk
activ
central
peripher
naloxon
antagon
increas
serum
inflammatori
cytokin
induc
central
administr
interleukinla
might
also
reduc
deleteri
behavior
effect
lnterferona
given
icv
also
detriment
produc
stressrel
respons
reduc
nk
activ
action
revers
icv
naltrexon
suggest
possibl
explan
immunosuppress
associ
kind
opiatemedi
stress
evid
relationship
opiat
immun
system
stress
find
restraint
produc
decreas
immunoreact
periaqueduct
gray
interferoni
product
splenocyt
although
mechan
involv
delin
sex
differ
chang
immun
function
greater
femal
male
signific
find
unclear
opiatemedi
intermitt
shock
increas
concentr
splenocyt
lymphocyt
peripher
blood
mononuclear
cell
nonopi
continu
shock
opiat
system
clearli
involv
food
restrict
increas
basophil
frequenc
heterophillymphocyt
ratio
increas
dynorphin
leuenkephalinlik
immunoreact
brain
indic
correl
opiat
immun
respons
effect
coldwat
swim
immun
system
depend
frequenc
occurr
three
swim
day
reduct
product
mitogen
respons
concanavalin
lipopolysaccharid
percentag
nk
lymphocyt
day
swim
one
session
per
day
respons
enhanc
perhap
reflect
differenti
stress
event
effect
forc
swim
handl
loud
nois
reduc
cinterferon
naloxon
naloxonazin
revers
action
naltrindol
norbinaltorphimin
alter
suggest
neuromodulatori
effect
ainterferon
mediat
receptor
explan
involv
immun
system
opiat
depend
suggest
wellmaintain
opiat
depend
benefici
organ
opiatena
individu
opiat
exposur
activ
stress
axi
produc
homeostat
disrupt
immunolog
disrupt
opiat
exposur
continu
howev
homeostat
immunolog
respons
stabil
way
individu
becom
depend
opiat
withdraw
produc
imbal
destabil
disrupt
immun
function
may
assum
immun
system
compromis
procedur
support
involv
opiat
immun
activ
demonstr
chang
opiat
tumor
patient
gynecolog
malign
higher
normal
control
suggest
peptid
may
involv
develop
cancer
modul
cell
immun
strong
neg
correl
howev
metenkephalin
degre
ot
malign
patient
brain
tumor
enkephalin
may
repres
use
malign
marker
tumor
similarli
indic
immun
function
may
involv
endogen
opiat
upregul
opiat
system
measur
proenkephalin
synthesi
pertussi
toxin
atrial
natriuret
factor
coexpress
small
popul
macrophag
suggest
may
comodul
aspect
immun
function
lipopolysaccharid
increas
enkephalin
mrna
although
time
chang
coincid
suggest
feedback
mechan
rather
potenti
lnterleukinla
produc
releas
vivo
anterior
pituitari
vitro
vivo
action
probabl
occur
higher
level
perhap
hypothalamu
cn
control
hypothalamu
thu
highli
complex
relationship
opiat
immun
system
remain
far
elucid
among
behavior
previous
shown
mediat
part
opiat
system
social
interact
includ
prosoci
agonist
encount
continu
studi
morphin
reduc
distress
vocal
isol
young
chick
greatli
inhibit
roughandtumbl
play
juvenil
rat
repeat
administr
day
weak
toler
develop
could
block
coadministr
nmda
antagonist
mk
indic
possibl
interact
opiat
nmda
receptor
respons
distress
vocal
typic
occur
home
cage
litterm
elicit
inject
mean
find
opiat
mediat
clear
naltrexon
effect
kinduc
behavior
prefer
isol
rat
pup
show
smell
soil
bed
home
cage
oppos
clean
wood
chip
affect
naltrexon
indic
lack
opiat
mediat
instead
respons
alter
clonidin
indic
involv
system
ultrason
vocal
adult
male
rat
threat
attack
residentintrud
clash
attenu
morphin
naltrexonerevers
way
audibl
vocal
unaffect
thu
opiat
influenc
affect
respons
avers
social
situat
wellknown
antituss
action
opiat
agonist
studi
confirm
previou
find
morphin
damgo
reduc
cough
although
dalaz
deltorphin
ii
alon
effect
enhanc
antituss
action
damgo
naloxon
antagon
action
morphin
damgo
antagonist
naloxonazin
indic
involv
receptor
support
conclus
fact
mice
defici
u
receptor
show
respons
abil
flendorphin
inhibit
cough
furthermor
revers
antagonist
k
antagonist
norbinaltorphimin
implic
receptor
effect
morphin
greater
diabet
nondiabet
rat
antagonist
naltrindol
wipe
differ
suggest
involv
k
receptor
also
evid
involv
receptor
came
find
naltrindol
alon
suppress
cough
diabet
rat
potenti
damgo
antituss
action
agonist
deltorphin
ii
blockad
synergist
effect
deriv
naltrindol
opiat
system
may
also
involv
physiolog
rhythm
diurnal
season
morphin
inject
differ
time
cycl
advanc
phase
circadian
wheel
run
case
delay
other
frequent
produc
bout
intens
wheel
run
diurnal
variat
plasma
concentr
coincid
elev
pain
threshold
largest
pupil
diamet
increas
heart
rate
suggest
possibl
regulatori
function
peptid
respons
circadian
rhythm
concentr
metenkephalin
neurointermedi
pituitari
peak
occur
day
night
cortic
concentr
leuenkephalin
peak
day
striatum
measur
peak
night
thu
show
attenu
cycl
mechan
hibern
might
season
increas
endogen
opiat
system
produc
downregul
hippocamp
opiat
receptor
could
induc
heighten
serotonerg
activ
support
idea
came
find
dadl
inhibit
serotonin
normal
hibern
similarli
enhanc
releas
serotonin
slice
hippocampu
nonhibern
hibern
potenti
inhibit
norbinaltorphimin
implic
receptor
damgo
inhibit
serotonin
releas
hippocampu
slice
naloxonerevers
way
hibern
nonhibern
ground
squirrel
hypotfialamu
damgo
produc
releas
serotonin
state
indic
complex
natur
role
differ
opiat
regular
hibern
pruritu
anoth
behavior
previous
shown
mediat
opiat
system
confirm
morphin
produc
itch
human
pupillari
respons
also
occur
opiat
hydromorphon
pentazocin
caus
constrict
pupil
dilat
associ
increas
enkephalinlik
immunoreact
axon
margin
region
avian
auditori
thalamu
perikarya
medial
margin
inferior
colliculu
appear
enkephalinerg
auditori
pathway
parallel
tradit
recogn
auditori
pathway
target
region
avian
basal
forebrain
suggest
role
enkephalin
auditori
process
dryness
mouth
caus
fraction
irradi
head
neck
associ
markedli
enhanc
leuenkephalinlik
immunoreact
submandibular
ganglion
cell
increas
number
nerv
fiber
show
immunoreact
opiat
system
may
mediat
dryness
opiat
system
may
play
role
nicotin
depend
naloxon
precipit
withdraw
rat
made
depend
week
nicotin
infus
morphin
reduc
spontan
absenc
sign
termin
nicotin
nicotin
also
produc
naloxonerevers
antinocicept
mice
lower
dose
antagon
morphin
analgesia
thu
dual
action
involv
opiat
agonist
antagonist
properti
suggest
analges
nitrou
oxid
ga
consid
opiat
crosstoler
morphin
blockad
naloxon
stereospecif
agent
inhibit
breakdown
potenti
respons
block
opiat
antagonist
produc
releas
endogen
opiat
low
concentr
compet
opiat
ligand
bind
site
opiatelik
effect
also
report
transport
brain
satur
system
peptid
transport
way
similar
less
robustli
physiolog
role
famili
like
opiat
peptid
remain
elucid
